TABLE OF CONTENTS
Page
Page
Welcome to the 9th ESSM Congress ................2
Opening Ceremony ..........................................17
ESSM History ......................................................4
Program Schedule ............................................18
ESSM Committees ..............................................5
Scientific Program
Sunday, 3 December 2006 ................................23
Monday, 4 December 2006 ..............................25
Tuesday, 5 December 2006 ..............................31
Wednesday, 6 December 2006..........................37
ESSM Award Winners ........................................6
Acknowledgements ..........................................6
Hofburg Congress Center Floor Plan ................7
General Information
Congress Registration Counter ............................8
Registration Fees ................................................8
Congress Language ............................................9
Congress Documentation ....................................9
Congress Information System
CO CONGRESS ONLINE® ..................................9
Speakers Service Centre and Lounge ..................9
ESSM Membership Issues ....................................9
Name Badges ......................................................9
Technical Exhibition ............................................9
Poster Exhibition................................................10
Poster CD ROM ................................................10
Internet Centre..................................................10
Press..................................................................10
Messages ..........................................................10
Restaurants ......................................................10
Coffee Breaks ................................................10
Cloakroom ........................................................10
Bank ................................................................11
Currency ..........................................................11
Electricity ..........................................................11
Lost and Found ................................................11
Mobile Phones ..................................................11
Program Changes..............................................11
Insurance ........................................................11
Airport ..............................................................11
Car Park ..........................................................11
Taxis ..................................................................11
Public Transportation Pass ................................12
How to get to the Hofburg Congress Center ....12
Supporting Program ........................................13
Introduction to the Scientific Program
Format Descriptions ..........................................14
CME Credits......................................................15
ESSM Grants and Awards..................................16
Poster Presentations ........................................38
List of Exhibitors and Map ..............................54
List of Chairpersons and Presenters ..............55
Congress and Exhibition Office
CPO HANSER SERVICE
Hanser & Co GmbH
P.O. Box 1221, 22882 Barsbüttel, Germany
Telephone: +49-40-670 88 20
Telefax:
+49-40-670 32 83
E-Mail:
[email protected]
ESSM Secretariat
Lavinia Ricci
c/o AISC & MRG srl AIM Group
Via Ripamonti 129, 20141 Milan, Italy
Telephone: +39-025-6601 289
Telefax:
+39-027-0048 577
E-Mail:
[email protected]
Scientific Secretariat
Petter Hedlund
Department of Clinical Pharmacology
Lund University Hospital, 22 185 Lund, Sweden
Telephone: +46-46-173 35 1
Telefax:
+46-46-211 19 87
E-Mail:
[email protected]
Congress Venue
Hofburg Congress Center
Heldenplatz, 1014 Vienna, Austria
1
2
WELCOME TO THE 9TH ESSM CONGRESS
Dear Colleagues,
I cordially welcome you to the 9th Congress of the European Society for Sexual
Medicine in Vienna, to be held from December 3 – 6, 2006.
The ESSM Congress is the most important event of our association and I am sure
that it will be a great success for several reasons.
S. Meryn
The first reason is the programme. The programme organised by the ESSM
Scientific Committee is very attractive for all practicing physicians with many
debates and lectures on the different fields of sexual medicine. You will also be
updated about all new technologies and treatments which will assist you in your
daily practice.
The second reason is the scientific one. The congress provides an excellent forum
for active participation of basic research and clinical scientists. All scientists, and
especially younger and more junior scientists, have been invited to submit
abstracts for oral and poster presentations. The congress schedule provides
ample opportunities for informal personal exchanges of ideas, data and findings,
which we hope will stimulate international collaborations.
The third reason is that Vienna is one of the most beautiful cities in the world,
with a breathtaking range of social and entertainment opportunities, and is one
of the centres of European culture in the heart of Europe. We also invite your
partners to Vienna not to miss the opportunity to share with us a spectacular
social programme for the accompanying people which will be particularly prepared
for them.
In addition, 2006 we celebrate the 250th anniversary of the birth of Wolfgang
Amadeus Mozart, the most famous Austrian of all time. Austria is honouring this
musical genius with a rich and varied calendar of extraordinary concerts, festivals, galas, expos and special exhibitions in Vienna.
I look forward to welcoming you to the 9th ESSM Congress in Vienna.
Prof. Siegfried Meryn, MD
Chairman 9th ESSM Congress
WELCOME TO THE 9TH ESSM CONGRESS
Dear ESSM Members,
Dear Friends,
On behalf of the Executive and Scientific Committee of ESSM, I would like to
welcome you to the 9th annual meeting of our Society in the beautiful city of
Vienna.
The scientific programme is outstanding and I am sure that you will all enjoy
attending the various sessions covering the hottest topics in the field of Sexual
Medicine. I am particularly grateful to the Chairman and Members of the
Scientific Committee of ESSM who have devoted a significant amount of energy
in organizing the best possible programme for you.
F. Montorsi
We received the highest number of abstracts in the history of ESSM and we did
our best to select those who would capture your interest and would stimulate a
lively discussion.
During the meeting in Vienna, you will have the opportunity to attend the scientific sessions organized in collaboration with a number of sister Scientific
Societies. This will give our meeting the widest international scientific breath.
Our Society has been growing fast and I am proud to inform you that we
currently have 19 National Societies of Sexual Medicine officially affiliated to
ESSM. The future success of ESSM is certainly based on the capacity to spread
our scientific knowledge as much as possible throughout whole Europe, in the
ultimate interest of the best possible patients' care.
I would finally like to thank Prof. Siegfried Meryn and all members of the
Organizing Committee for the hard work done in organizing an elegant meeting, allowing us to taste the Vienna atmosphere which culminates at Christmas
time.
Welcome to Vienna and enjoy the Meeting.
Warmest regards
Prof. Francesco Montorsi, MD
President, ESSM
3
4
ESSM HISTORY
President
ESSM Congress Venues and Chairmen
Prof. Francesco Montorsi
Department of Urology
Universita' Vita Salute San Raffaele
Via Olgettina 60
20132 Milan, Italy
Telephone: +39-02-2643 7286
Telefax:
+39-02-2643 7298
E-Mail:
[email protected]
1995
Porto Carras, Greece
Dimitrios Hatzichristou, Greece
1997
Madrid, Spain
Inigo Saenz de Tejada, Spain
2000
Barcelona, Spain
Halim Hattat, Turkey
2001
Rome, Italy
Francesco Montorsi, Italy
2002
Hamburg, Germany
Hartmut Porst, Germany
2003
Istanbul, Turkey
Emre Akkus, Turkey
2004
London, UK
David Ralph, UK
2005
Copenhagen, Denmark
Petter Hedlund, Sweden
2006
Vienna, Austria
Siegfried Meryn, Austria
2007
Lisbon, Portugal
Nuno Monteiro Pereira, Portugal
2008
Brussels, Belgium
Joint Congress of ISSM/ESSM
Eric Wespes, Belgium (ISSM)
Claude Schulman, Belgium (ESSM)
ESSM Secretariat
Lavinia Ricci
c/o AISC & MRG srl AIM Group
Via Ripamonti 129
20141 Milan, Italy
Telephone: +39-025-6601 289
Telefax:
+39-027-0048 577
E-Mail:
[email protected]
Chairperson of the 9th ESSM Congress
Prof. Siegfried Meryn
President ASSM
Medical University of Vienna
Währinger Gürtel 18 - 20, P.O.Box 10
1097 Vienna, Austria
Telephone: +43-1-409 60 10
Telefax:
+43-1-409 60 11
E-Mail:
[email protected]
ESSM Presidents
1993-1997
1997-1999
1999-2001
2001-2004
2004-2007
Gorm Wagner, Denmark
John Pryor, UK
ESSM COMMITTEES
Executive Committee
President:
President Elect: Ian Eardley, UK
Secretary
General:
Treasurer:
Members:
John Dean, UK
Ian Eardley, UK
Carlo Bettocchi, Italy
Juza Chen, Israel
Beatrice Cuzin, France
Kerstin S. Fugl-Meyer, Sweden
Annamaria Giraldi, Denmark
Ates Kadioglu, Turkey
Ethical
Chair:
Members:
Female Sexual Health
Chair:
Members:
Ellen Laan, The Netherlands
Roy Levin, UK
Ilan Gruenwald, Israel
David Goldmeier, UK
Primary Care
Chair:
Members:
Scientific Committee Vienna 2006
Chair:
Members:
John Dean, UK
Francois Giuliano, France
Geoffrey Hackett, UK
Antonio Martin-Morales, Spain
Ignacio Moncada, Spain
Marcel D. Waldinger,
The Netherlands
Kevan Wylie, UK
Clinical
Chair:
Members:
Javier Angulo, Spain
Mario Maggi, Italy
Stephan Ückert, Germany
Alberto Briganti, Italy
Ian Eardley, UK
Dirk Schultheiss, Germany
Geoffrey Hackett, UK
Bert-Jan de Boer, The Netherlands
David Edwards, UK
Doug Savage, UK
Psychosexual
Chair:
Kevan Wylie, UK
Members:
Loukas Athanasiadis, Greece
Marie Chevret-Measson, France
Emmanuele Jannini, Italy
Chiara Simonelli, Italy
Mehmet Sungur, Turkey
Surgery
Chair:
Members:
Sub Committees
Basic Science
Chair:
Members:
Marcel D. Waldinger, The Netherlands
Ulf Simonsen, Denmark
Fulvio Colombo, Italy
Sava Perovic, Serbia and Montenegro
David Ralph, UK
National Organization Committee
Chair:
Members:
Elia Bragagna, Austria
Bob Djavan, Austria
Andreas Jungwirth, Austria
Michael Marberger, Austria
Eugen Plas, Austria
Marianne Springer-Kremser, Austria
Walter Stackl, Austria
Astrid Zeitelberger-Renz, Austria
5
6
ESSM AWARD WINNERS / ACKNOWLEDGEMENTS
ESSM Award Winners
ESSM Award Winners
Best Presentation Awards
Career Awards
1995
Christian Stief, Germany
2002
John Pryor, UK
1997
Paul F. Engelhardt, Germany
Suks Minhas, UK
2003
Gorm Wagner, Denmark
2004
Giles Brindley, UK
Ronald Virag, France
2005
Karl-Erik Andersson, Sweden
2000
Apostolos Apostolidis, Greece
F. Mumtaz, UK
2002
2003
Stefan Ückert, Germany
Mustafa Usta, Turkey
2004
2005
Byoung Ahn, Republic of Korea
Antonio Aversa, Italy
Award of Excellence
2002
2003
Selim Cellek, UK
2004
2005
Ekkehard W. Hauck, Germany
Giovanni Corona, Italy
Elke Gizewski, Germany
Attila Kun, Hungary
Acknowledgements
The organizers of the 9th Congress of the European Society for Sexual Medicine gratefully acknowledge the
support of the following companies (as per November 2006)
Major Sponsors
Bayer HealthCare AG
Lilly ICOS LLC
Pfizer Inc.
Sponsors
American Medical Systems Europe B.V.
Ardana Bioscience Ltd.
Coloplast (former Mentor Porges)
Ipsen Pharma
Janssen-Cilag Pharmaceutica NV
Nature Publishing
Plethora Solutions/Timm Medical Technologies
Procter & Gamble Pharmaceuticals
Schering AG
Solvay Pharmaceuticals GmbH
Uroan 21
HOFBURG CONGRESS CENTER - FLOOR PLAN
HOFBURG CONGRESS CENTER
Ground Floor
Botschafterstiege
Schatzkammersaal
Forum
Feststiege
(Stairs to 1st Floor)
Gardehalle I and II
Counter
Cloakroom
Poster Exhibition
Prinz-Eugen-Saal
Speakers Centre
and Lounge
First Floor
Entrance
Heldenplatz
Exhibition Area
Radetzky III
Marie
Theresien III
Radetzky I
Theathergang
Radetzky II
Press
Office
Botschafterstiege
Internet
Centre
Künstlerzimmer
Marmorsaal
Zeremoniensaal
Geheime
Ratstube
Marie
Theresien II
Antekammer
Rittersaal
Trabantenstube
Hofburg
Galerie
Seitengalerie
Festsaal
Heldenplatz
(Stairs to
Ground Floor)
Feststiege
7
8
GENERAL INFORMATION
Congress Registration Counter
Registration/Check-in and arrival at the congress
All congress materials and documentation will be
available at the congress registration counter located
in the entrance foyer of the Hofburg Congress Center
in Vienna.
Opening hours
Sunday, 3 December 2006
Monday, 4 December 2006
Tuesday, 5 December 2006
Wednesday, 6 December 2006
8.00
7.00
7.30
7.30
-
19.30
19.30
18.00
12.30
h
h
h
h
During these opening hours the congress counter can
be reached at:
Telephone: +43-1-536 44-223
+43-1-536 44-224
Telefax:
+43-1-536 44-226
ESSM Members, Physicians (MD)
EUR 500
Non-Members, Physicians (MD)
EUR 600
ESSM Members with reduced fees*
Nurses, Residents in Training,
Scientists (PhD), Psychologists,
Therapists, Students
EUR 400
Non-Members with reduced fees*
Nurses, Residents in Training,
Scientists (PhD), Psychologists,
Therapists, Students
EUR 500
Retired Delegates
EUR 80
Accompanying Persons
EUR 85
* A letter of the Chairman of the Department is necessary.
Registration fee for participants includes:
The congress counter will be divided into the
following sections:
On-Site Registration
On-site registration for the congress.
Pre-Registration
Participants who have already registered for the
congress will receive their documents here.
Hotel Reservations
Assistance for the reservation of hotel rooms in
Vienna will be provided here.
Information
The staff of the information counter will be pleased
to provide you with information about the congress,
the congress centre, the hotels and the city of Vienna.
They will also assist with restaurant information.
Press Accreditation
Press who has already pre-registered or will register
on-site. For press accreditation an official press identity card is required.
Admission to all scientific sessions
Admission to the poster and technical exhibition
Admission to the ESSM Gala Opening Ceremony
and Welcome Reception on 3 December 2006
Conference materials (delegate bag, final program, abstract book, etc.)
Coffee breaks and lunches from Monday,
4 December 2006 until Wednesday, 6 December
2006 ending with a coffee break in the morning.
Use of the Vienna public transportation system
from Sunday, 3 December 2006 to Wednesday,
6 December 2006
Registration fee for accompanying persons
includes:
Admission to the ESSM Gala Opening Ceremony
and Welcome Reception on 3 December 2006
Half Day City Sightseeing Tour of Vienna
(pre-registration necessary)
Use of the Vienna public transportation system
from Sunday, 3 December 2006 to Wednesday,
6 December 2006
GENERAL INFORMATION
Congress Language
The congress language is English. Simultaneous translation will not be provided.
Congress Documentation
The ESSM will offer its members to view parts of the
scientific schedule online through a web-based
system from the new ESSM homepage. Therefore
several lectures will be filmed during the congress.
will be available afterwards on a special congress
notebook in the hall of the presentation. Due to time
and technical reasons we kindly ask the speakers not
to use their own notebook. Several PC working stations
are provided in the speakers centre where speakers
can also work on their PC charts in a quiet area.
Technical staff will be glad to assist.
A speakers lounge is provided in a separate area of
room Erzherzog Karl Saal. Please see as well page 7.
ESSM Membership Issues
Congress Information System
www.essm2006.org
Participants can benefit from the web based ESSM
Congress Information System CO CONGRESS
ONLINE® on-site in the exhibition hall at the Internet
centre. They can set up and print out a personal congress program schedule. The ESSM Congress
Information System provides information on:
Updated scientific program
Program by day
Program by formats with accepted abstracts of
chairpersons and speakers
Program search
List of participants (who is who)
For ESSM membership issues and any other ESSM
business, please contact our ESSM booth which is
situated in the exhibition area, at the Trabantenstube.
Name Badges
All participants are strongly requested to wear their
name badge at all times during the congress. The
colours of the name badge have the following significance:
Delegate:
Accompanying person:
Press:
Exhibitor:
Staff:
Blue
Orange
Yellow
Green
Red
List of exhibitors and sponsors
General congress information
Technical Exhibition
A major technical exhibition will take place on the
first floor of the Hofburg Congress Center next to the
main meeting rooms. Coffee bars and catering stations
will be set up at various areas in the technical exhibition. For further information, please see page 55.
(List of exhibitors)
Private mailbox
Speakers Centre and Lounge
The speakers centre and lounge is located in the
Erzherzog Karl Saal on the ground floor.
Speakers are asked to hand in their CD ROM or USB
stick, containing the PowerPoint presentation (IBM
format or compatible, no multisession) preferably one
day before their presentation but at the latest
90 minutes prior to the presentation. The presentation
will be transferred to the central congress server and
Opening hours
09.00 – 17.00 h
09.00 – 17.00 h
Wednesday, 6 December 2006 09.00 – 12.30 h
9
10
GENERAL INFORMATION
Poster Exhibition
Press
The moderated posters will be located in and in
front of the Forum. All moderated poster sessions will
take place in the Forum. The moderated posters in the
room will be changed daily according to the sessions.
The press centre is set up in the Maria Theresien
Appartments on the first floor of the Hofburg
Congress Centre. It is open from Monday,
4 December through Wednesday, 6 December 2006.
The press centre is managed by the press agency
FCB Events & PR.
The unmoderated posters will be sited in the
Gardehalle I and II next to the main meeting rooms
Forum and Prinz Eugen Saal and the registration
counter on the ground floor of the Hofburg.
All moderated and unmoderated posters will be displayed during the whole conference. They will be
arranged according to topics and will be numbered
within the topics. The poster exhibition is open to all
participants:
Monday 4 December 2006
09.00 – 17.30 h
Tuesday 5 December 2006
09.00 – 17.30 h
Wednesday 6 December 2006 09.00 – 12.30 h
Interested participants can meet the authors for discussion of their posters during following times:
15.00 - 15.30 h
15.00 - 15.30 h
Poster CD ROM
A CD ROM including all poster presentations will be
produced and all delegates will receive the poster CD
ROM by post after the congress. All poster authors
who have not yet submitted their poster are kindly
asked to do so electronically either on CD ROM or on
USB stick at the speakers centre.
Internet Centre
Several Internet terminals are available to all delegates at the exhibition area at the Entreezimmer of the
Hofburg Congress Center. The Internet centre is
accessible according to the opening hours of the
exhibition.
Messages
A message board will be available at the registration
area of the congress.
Restaurants
During the congress on Monday and Tuesday a complimentary snack buffet will be offered during lunch
time for all registered congress delegates. Various
restaurants and typical Viennese Cafés can be found
in walking distance of the congress venue.
Coffee Breaks
Coffee and tea are served during the morning and
afternoon coffee breaks from Monday, 4 December
to Wednesday, 6 December 2006 free of charge to all
participants wearing congress name badges. Various
coffee stations are located in the exhibition area of
the Hofburg Congress Center.
Cloakroom
A cloakroom is available next to the registration
counter on the ground floor. You can also store your
luggage here.
GENERAL INFORMATION
Bank
Insurance
An ATM/cash machine is located outside the Hofburg
Congress Center at the Michaelerplatz within two
minutes walking distance.
The congress fee does not include insurance. All participants are advised to arrange for their own insurance.
Health and accident insurance is recommended and
has to be purchased in your country of residence. The
organisers will not be responsible for a loss or damage of personal belongings.
Currency
The Euro is the official currency in Austria. Exchange
of foreign currency is available at the Vienna Airport
and at most hotels, banks and exchange offices
throughout the city.
Electricity
Austria uses a 230 volt 50Hz system. Sockets have
the European standard and plugs are two-prong
grounded.
Airport
Vienna International Airport – Schwechat is in 15 km
distance to the city centre. The express direct train
CAT departs every 30 minutes from the International
Airport to the Vienna city centre and takes 16 minutes.
A one way ticket costs EUR 9. Within Vienna the
Hofburg is easy accessible by public transportation.
The taxi fare from the airport to any of the congress
hotels and congress venue is expected to be approximately EUR 50.
Lost and Found
A lost and found service is available at the Hofburg
Congress Center Information located in the entrance
foyer of the congress venue.
Car Park
Parking space is available next to the Hofburg
Congress Center and participants arriving by car are
advised to use these facilities. Parking fees are not
included in the registration fee.
Mobile Phones
Participants are kindly requested to keep their mobile
phones turned off while attending the scientific
sessions in the meeting rooms.
Program Changes
The organisers cannot assume liability for any
changes in the congress program due to external or
unforeseen circumstances.
Taxis
Taxis are available upon demand in front of the
entrance of the Hofburg Congress Center.
Participants can also call taxis at the Hofburg
Congress Center information counter in the entrance
foyer.
11
GENERAL INFORMATION
Public Transportation Pass
How to get to the
Hofburg Congress Center
Registered participants receive a public transportation
pass in exchange for a voucher which is included in
the participants’ congress materials. The congress
materials can be picked up at the congress counter
upon arrival. The public transportation pass is valid
for all public transportation during the congress
period, i.e. from Sunday, 3 December 2006 through
Wednesday, 6 December 2006. Vienna’s public transportation system includes subways, trams and buses.
Most of the hotels available are located in the city
centre and are easy to be reached by public transportation from the congress venue.
tte
nr
i
Bus
2A, 3A (exit Michaelerplatz)
ho
Schottentor
ho
Tram
D, J, 1, 2 (exit Burgring)
i
Sc
Sc
Underground / U-Bahn
U1 (exit Stephansplatz)
or
U3 (exit Herrengasse)
Ka
U2
tte
ng
as
se
2A
,3
A
Tu 2A
ch , 3
la A
ub
e
Schwedenplatz
ey
un
g
Ring
Dr. K.
Renner
2A
,3
A
Herrengasse
MICHAELERPLATZ
hauflerg.
Sc
U1
STEPHANSPLATZ
U3
H
City Airport
Terminal
O
Stephansplatz
FB
U
Strafle
fs t
g
rin
en
ub
tr.
eth
ers
by car
rs
tr.
in
OPER
g
D, J K
,
D, J 1
,2
U2
3A
er R
in
g
Parkgarage
Oper
U1 Sc
M useumsquartier
Parkgarage
Le M eridien
le
ei
kr in
You
reach
the Hofburg
Youcan
can
reach
us via via
public
transportation:
public
transportation:
Underground: U1, U3
Underground:
Tramway:
D, J, 1, 2 U1, U3
Tramway: 2A, 3A D, J,1,2
Bus:
Bus:
U4
rg
RICHTUNG
A2 S‹ DAUTOBAHN
nbe
Congress Entrance at Heldenplatz
Par
rze
nz
Stadtpark
ing
wa
Li
ie
W
ertr
KARLSPLATZ
U2
e
nk
hub
Karlsplatz
U4
Sch
2A
RICHTUNG
A1 WESTAUTOBAHN
1
ge
2
tz
er
g
la
nb
r
sp
B
e
ab
rn
m
pe
eu
O
us
St
g
RICHTUNG
FLUGHAFEN
of
rin
M
Parkgarage
useumsquartier
Tramway
Underground
Bus
U4
Landstrasse U3
Te
g
J,
2A
MARIA
THERESIEN
PLATZ
g.
r.
tin
3AAugus
rg1
BJu,
2
D,
D,
Volkstheater
en
K r
tn er
RG
CAT
P3laA
nk
JOSEFSPLATZ
HELDENPLATZ
U3
U1
U3
L
Parkgarage
Rathaus
U4
n
Fr
L welstra
Dr. K.
Leuger
Ring
A
,3
2A
AM HOF
D, J, 1
D, J, 2
RATHAUSPLATZ
e
ss
12
2A, 3A
Josefsplatz no parking-site!
Only for delivery
Josefsplatz no parking-site!
(freight vehicles below 7,5t)
Only for delivery
(freight vehicles below 7,5t)
SUPPORTING PROGRAM
Official ESSM
Vienna Sightseeing Tour
14.00 - 17.30 h
This tour includes the main sights and highlights of
Vienna. It starts with a drive along the famous
Ringstrasse with its magnificant buildings, such as the
Vienna State Opera, the Imperial Palace, the Museum
of Fine Arts and the Museum of Natural History.
“Following Sisi’s Footsteps...”
Tuesday - Saturday
9.45 - 13.15 h
Discover some of the delightful features of Vienna on
a stroll through the center of Vienna. We start our
walk with a visit to the Imperial Crypt, the burial of
the Habsburgs, where Empress Elisabeth "Sisi" is also
buried. Before a visit to the Hofburg Palace, the former official residence of Sisi and Franz Josef, you have
the possibility to watch the training of the world
famous Lipizzaner horses. Here the tradion of the
High School of Riding is still cherished. The tour ends
at the Hofburg. Entrance fee for the Spanish Riding
School has to be paid seperately.
Price per person: EUR 37
For information and booking, please contact:
Mrs Michaela Ulreich
[email protected]
Phone: 0043-1-712 46 83 80
www.viennasightseeing.at
The tour continues to Schönbrunn Palace. The former
summer residence of the Habsburg family with its
more than 1400 state rooms and the extensive park
is a splendid example of Baroque culture. A 45-minutes highlight tour takes you to 22 splendid rooms,
such as the Grand Gallery and the Chinese Cabinets.
After the tour there will be some free time to explore
one of the nicest Christmas Markets in Vienna, called
Ehrenhof right in front of the palace, this includes a
16 m high illuminated Christmas tree. The Christmas
market invites to stroll around the market, taste some
hot wine and Austrian Christmas cookies or buy some
Christmas gifts there.
On the way back the tour passes by the Belvedere
Palace, the former summer residence of Prince
Eugen, which houses the largest Gustav Klimt collection in the world.
This tour will start and end at the Vienna Hofburg.
Places are limited and will be assigned on a firstcome, first-served basis.
Price per person: EUR 45
For registered accompanying persons this tour is
complimentary.
Meeting point is the main entrance of the congress at
the Heldenplatz.
Strauss and Mozart Concert at the
Kursalon
Daily 20.00 h
The “Salonorchester Alt Wien”, one of the best
known performers of Viennese classical music, ignites
explosive fireworks with the most beautiful of compositions by "Waltz King" Johann Strauss and his
contemporaries. Virtuosic musicians, extraordinary
opera singers, and enchanting ballet dancers present
an evening filled with Viennese charm and joyful
waltzes, polkas, and operetta melodies of the highest
artistic calibre.
For information and booking, please contact:
[email protected]
Phone: 0043-1-512 57 90
www.soundofvienna.at
Reference for special rates: ESSM 2006
13
14
INTRODUCTION TO THE SCIENTIFIC PROGRAM
Structure of the Scientific Program
The scientific program is structured according to
days. Per day it is structured by time and room. All
presenters are listed by name and the title of their
presentation.
Structure of the Abstract Book
The abstract book is structured by session format.
The listing starts with the podium session followed
by the moderated poster sessions. Hereafter the
unmoderated posters are listed according to
topics.
FORMAT DESCRIPTIONS
Master Lecture
Debates
Each lecture of 30 minutes will be given by a distinguished and renowned expert and will be devoted to
a specific topic of major interest.
Debates last for 60 minutes and are designed to cover
controversial issues of a particular topic. The moderator will allow a short introduction for each topic by
the respective opponents followed by a discussion on
the arguments proposed. Comments, arguments,
and questions from the floor are welcomed during
the discussion.
Round Table
These sessions will usually last 90 minutes. They will
focus on a particular topic and present the very latest
data related to it. The round table will include a maximum of four papers and time for discussion.
Best Papers
A selection of the year’s original scientific publications
of particular importance for a specific topic within
sexual medicine will be highlighted by the chairpersons during 90 minutes. Each paper will be briefly
summarized and discoveries or other information of
special interest will be given attention in relation to
current knowledge and future perspectives.
Interactive Sessions
These sessions will last 90 minutes and present case
discussions with a questioner and a panel of
experts. Attendees will be given the possibility to
interact actively via a voting system with the faculty of
the session.
Point-Counterpoint Sessions
These sessions are organized to address one controversial issue of a topic. The moderator will allow a
brief introduction for each topic by the respective
opponents followed by a discussion on the arguments proposed.
Instructional Courses
These 90 minutes sessions present a detailed account
of a chosen topic. Courses are designed to provide
learning experiences that actively involve participants
and will include an opportunity for informal exchange
with the faculty.
INTRODUCTION TO THE SCIENTIFIC PROGRAM
Podium Sessions
Symposia organized by the Industry
Podium Sessions will present the best abstract papers
accepted for the congress by the Scientific
Committee and will focus on specific topics presenting the very latest findings in this field. Each session
will last 90 minutes and will consist of max. 10 presentations per session. Each presentation is limited to 7
minutes followed by 2 minutes of discussion.
Symposia organised by the Industry in consultation
with the Scientific Committee will be presented at the
afternoon on Sunday, 3 December 2006 before the
Gala Opening and on Monday, 4 December 2006 and
Tuesday, 5 December 2006 during lunchtime and in
the late afternoon.
CME (Continuing Medical Education)
Moderated Poster Sessions
Authors were invited to submit papers on their latest
research findings or important ongoing research. The
moderated poster sessions were selected by the
Scientific Committee based on a review of all abstract
submissions. The most interesting posters are grouped by topic and presented in a 90-minute moderated session. Each session will consist of a maximum of
15 talks in the same general field. Each presentation
is limited to 4 minutes followed by 2 minutes of
discussion.
Posters
Authors were invited to submit papers on their latest
research findings or important ongoing research.
Posters were selected by the Scientific Committee
based on the review of all abstract submissions. The
most interesting posters are grouped into one of
16 general areas of research. The poster exhibition is
scheduled from Monday, 4 December, 2006 to
Wednesday, 6 December 2006 and will take place at
the Gardehalle I and II on the ground floor of the
Hofburg.
Video Surgery Course
The Video Surgery Course on Sunday, 3 December
2006, will last 120 minutes, each video has a duration
of 10 to 15 minutes. A panel of selected experts will
present surgical videos showing different techniques
and approaches and will discuss the details with the
participants.
This congress has been submitted for UEMS accreditation to the European Accreditation Council for
Continuing Medical Education (EACCME). Physicians
will be accredited with CME credits for the whole
period of the congress.
EACCME credits are recognised by the American
Medical Association towards Physician's Recognition
Award (PRA).
To convert EACCME credit to AMA PRA category
1 credit, please contact the AMA.
The accreditation form for international physicians is
available on the AMA website at www.ama-assn.org.
Choose the button ContMedEduc (CME) and follow
the link AMA PRA.
This congress has been submitted for CME accreditation to the Italian Ministry of Health. Physicians will be
accredited. You will find the CME evaluation forms in
your personal documents. Italian delegates are asked
to fill them in and leave them at the ESSM booth in
the exhibition area at the end of the congress. The
ESSM Secretariat will send the certificate after the
congress.
15
16
GRANTS AND AWARDS
Meeting Awards
The best presentations will be awarded with
EUR 2.000 by ESSM’s Award Committees.
1. Prize for the best presentation on FSD
(preclinical)
2. Prize for the best presentation on FSD (clinical)
3. Prize for the best presentation on MSD
(preclinical)
4. Prize for the best presentation on MSD (clinical)
5. Prize for the best surgical presentation
The ESSM Prestige Awards
The Executive Committee of ESSM decided to establish two awards to be presented during the annual
meetings of the society:
The ESSM Career Award
This award will be presented to a senior scientist
who has made an outstanding contribution in the
field. The Executive Committee has decided for
an award winner. The award winner will be presented during the Opening Ceremony.
The ESSM Award of Excellence
This award is presented annually to a young
scientist who has accomplished exceptional
achievement in the field. Eligible applicants are
physicians and scientists under the age of 40 with
significant contribution to the field.
EASM Fellowship Program and
Introductory Course
The European Academy of Sexual Medicine (EASM) is
a not-for-profit educational organisation with its
objective “to establish, harmonise and maintain standards for the education and practice of sexual medicine throughout Europe”. It was established as a
wholly independent body and with the full support of
the European Society for Sexual Medicine and the
European Federation of Sexology. One of its principal
aims is to establish a respected and academically rigorous qualification in sexual medicine for medical practitioners, the Fellowship of the EASM. The Fellowship
Program is open to candidates who are registered
medical practitioners, holding a specialist qualification
in an appropriate speciality, including family medicine/general practice. The fellowship will be awarded
to those who, following a prescribed period of professional training and practical experience, and attendance at approved structured courses, pass the required
examination and assessments. It is anticipated that
the first intake of candidates to the Fellowship
Programme will take place in December 2006 and
that the first introductory course will be held during
the ESSM 2006 Congress in Vienna. It is hoped that
the program will eventually be available in all
European countries, and be delivered in all European
languages. Initially, it will be available in English and
possibly in a limited number of other languages
according to demand and availability of learning/teaching opportunities.
OPENING CEREMONY
GALA OPENING CEREMONY followed by the ESSM WELCOME RECEPTION
Festsaal at the Hofburg, Sunday, 3 December 2006
18.15 – 20.30 h
Don’t miss the outstanding MOZART GALA
Throughout the world, Vienna has a reputation as the capital of music. The ESSM opening ceremony 2006
will be a celebration in honours of the unrivalled musical genius WOLFGANG AMADEUS MOZART, whose
250th birthday falls in 2006.
This extraordinary evening event dedicated to the probably most famous Austrian will be the social highlight of the 9th ESSM Congress besides the outstanding scientific program.
The welcome speeches from Prof. Montorsi, president of the ESSM and Prof. Meryn, local president of
the 9th congress of the European Society for Sexual Medicine will be accompanied by unique interpretations by members of the
World famous Vienna Philharmonic Orchestra and the Vienna State Opera Ballett
will be presented in the Festsaal at the Hofburg.
The music ensemble “Mozart Sinfonietta Wien” was founded in 1988 in Vienna, one of the most important cities in the life of Wolfgang Amadeus. This Viennese orchestra is dedicated not only to the performance of music by W. A. Mozart. Important part of its work is to find and perform new definitions of the
semantic contents in Mozart’s music.
Members of the “Mozart Sinfonietta Wien” are excellent musicians from the world famous Viennese
Symphonic Orchestras, mainly from the Vienna Philharmonic. All these brilliant musicians bring their large
experience and knowledge in to the work of the orchestra. At the same time traditional and evolutional,
the “Mozart Sinfonietta Wien” brings the genius of Mozart’s music close to its audience.
September 2005 marked a new departure for the Ballet of the Vienna State Opera and Volksoper, when
merging the previously completely separate ensembles of the two opera houses. This new policy will
enable the restructured ensemble to preserve the centuries-old tradition of the Vienna ballet as one of the
oldest and most legendary institutions in the filed of this genre.
The vienna waltz project was founded by soloist and dancers of the world famous Ballet of the Vienna
State Opera. To bring the fascination of creative dance performances to people all over the world is the
goal for the innovative work of these artists. Starting from classical ballet on highest level all sectors, stiles and forms of the art of dancing are developed. Modern dance, Vienna waltzes, Rap, Dance shows or
solo-ballet, Kuala Lumpur or Wolfgang-See – the vienna waltz project covers a big variation of performance styles and places. In Canada, the US, Moscow, Mallorca – everywhere these dancers conquer their
audience with innovative dance.
A multicoloured collage of dance and music, as animated and multifaceted as the life of Mozart himself
will ensure an unforgettable evening. At the end of the opening ceremony all participants are invited to
join a specially arranged Welcome Reception.
17
18
PROGRAM SCHEDULE
Room
Time
Festsaal
Zeremoniensaal
Various Meeting Rooms
09.00 -
Entrance Foyer
08.00 - 19.30 h
Registration at
the Entrance Area
09.30 10.00 10.30 11.00 11.30 -
Meetings of Affiliated
Societies
12.00 12.30 13.00 13.30 V-1
14.00 14.30 15.00 -
D-1
The JSM Debate
15.30 16.00 -
S-1
16.30 - New Developments in
Sexual Medicine, Schering AG
17.00 S-2 Clinical & Scientific
Advances in PE, Janssen-Cilag
17.30 18.00 -
Pharmaceutica NV
18.30 19.00 - Opening Ceremony
19.30 Welcome Reception
in the Entrance Hall of the Vienna Hofburg
20.00 20.30 -
Abbreviations
ML
Master Lecture
CP
Point Counterpoint Session
R
Round Table
C
B
Best Papers
HS
History Session
I
Interactive Session
P
Podium Session
D
Debate
S
Satellite Symposium
MP
V
Instructional Course
Moderated Poster Session
Video Course
PROGRAM SCHEDULE
Room
Time
Festsaal
Zeremoniensaal
Forum
Prinz Eugen Saal
07.00 - 19.30 h
Registration
at the
Entrance Area
08.00 -
ML-1
ISSM Lecture
08.30 ML-2
ISSWSH Lecture
09.00 ML-3
HIV-related FSD
09.30 Coffee Break
10.00 10.30 11.00 11.30 12.00 -
B-1
Erectile Dysfunction
Best Papers 2006
P-1
Hormones and
Sexuality
MP-1
Female Sexual
Health
C-1
How implant a
Penile Prosthesis
CP-1
ML-4 Quality of life
Hypogonadism and ED when treating ED
Lunch Break
12.30 -
S-3 Connecting the
Dots in ED Treatment:
13.00 - Erectile Function and
Satisfaction, Pfizer Inc.
13.30 14.00 14.30 -
I-1
B-2
Female Sexual Health Surgery/Peyronie’s
Best Papers 2006
P-2
Pathophysiology of
Sexual Dysfunctions
C-2
Testosterone
Replacement
15.00 Coffee Break
15.30 R-1
The Ageing Couple
16.00 -
MP-2
Pharmacology
16.30 17.00 -
S-4
Integrating Partners
into ED Treatment:
Unrealistic or
18.00 - Mandatory?
17.30 -
Bayer HealthCare AG
18.30 19.00 -
ESSM
Business Meeting
19.30 20.00 -
Entrance Foyer
Individual Dinner Invitations
C-3
Basics in Ejaculatory
Disorders
09.00 - 17.00 h
Exhibition
in various areas
of the Hofburg,
first floor
19
20
PROGRAM SCHEDULE
Room
Time
Festsaal
Zeremoniensaal
Forum
Prinz Eugen Saal
07.30 - 18.00 h
Registration
at the
Entrance Area
08.00 08.30
09.00
09.30
10.00
ML-5
ESAU Lecture
ML-6
SMSNA Lecture
ML-7
ESSM Award Lecture
Coffee Break
-
10.30 11.00 11.30 12.00 -
S-5 Satellite Symposium
Coffee Break
Solvay Pharmaceuticals
R-2
P-3
MP-3
More Hot Topics with Female Sexual Health Physiology and
PDE5 Inhibitors
Pathophysiology
C-4
Psychotherapies in
Premature Ejaculation
CP-2
HS-1
PDE5 Inhibitors for PE ESSM History Session
Lunch Break
12.30 -
S-6
From Clinical Study to
13.00 - Clinical Practice
Lilly ICOS LLC
13.30 14.00 - I-2
Ejaculatory Disorders
P-4
Pharmacology
MP-4
Surgery, Peyronie’s
Disease and Priapism
14.30 -
C-5
Basics in
15.00 Coffee Break
15.30 16.00 16.30 17.00 17.30 -
B-3
Female Sexual
Health
Best Papers 2006
P-5
C-6
Advanced ED
Management - from
Pharmacotherapy to
Penile Implant
S-7
Satellite Symposium
Procter & Gamble
Pharmaceuticals
18.00 18.30 19.00 -
Individual Dinner Invitations
19.30 20.00 -
Entrance Foyer
09.00 - 17.00 h
Exhibition
in various areas
of the Hofburg,
first floor
PROGRAM SCHEDULE
Room
Time
Festsaal
Zeremoniensaal
Forum
Entrance Foyer
C-7
Basics in Female
Sexual Health
07.30 - 12.30 h
Registration
at the
Entrance Area
08.00 I-3
08.30 Erectile Dysfunction
09.00 -
P-6
following Radical
Prostactectomy
09.30 Coffee Break
10.00 10.30 -
ML-8
R-3
Drug Misuse and Sexuality The ESDA Experience
B-4
Ejaculatory and Orgasmic
Disorders
11.30 - Best Papers 2006
11.00 -
12.00 Closing Remarks
12.30 -
P-7
Surgery and Peyronie’s
Disease
MP-5
General Issues in
Sexual Medicine
09.00 - 12.30 h
Exhibition
in various areas
of the Hofburg,
first floor
21
QBPQLPQBOLKBRKAB@>KL>QB
LK@BKQO>QFLKRKABO@LKQOLI
B?FALÜ FKGB@QFLKPMBOVB>ORPR>IIVJ>FKQ>FK
PBORJQBPQLPQBOLKBIBSBIPFKQEBMEVPFLILDF@>I
O>KDB

B?FALÜ ªBPQLPQBOLKBRKAB@>KL>QB«
OBP@OF?FKDKCLOJ>QFLK
EBO>MBRQF@FKAF@>QFLKP
BPQLPQBOLKB QEBO>MV FK @LKCFOJBA J>IB EVML¦
DLK>AFPJ
LJMLPFQFLK
JI PLIRQFLK @LKQ>FKFKD JD QBPQLPQBO¦
LKBRKAB@>KL>QB>P>@QFSBFKDOBAFBKQ>KA?BK¦
WVI?BKWL>QB>KA@>PQLOLFI>PBU@FMFBKQP
LKQO>FKAF@>QFLKP
>PBPLC HKLTKLOPRPMB@QBA>KAOLDBK¦ABMBK¦
ABKQ@>O@FKLJ>LC QEBMOLPQ>QBLOLC QEBJ>IB
J>JJ>OVDI>KAM>PQLOMOBPBKQIFSBOQRJLOP
EVMBOPBKPFQFSFQV QL QEB >@QFSB PR?PQ>K@BLO QL
>KVLC QEBBU@FMFBKQP
FABBCCB@QP
AJFKFPQO>QFLK PFQB M>FK >KA¥LO EBJ>QLJ>
LPPF?IB PVPQBJF@ PFAB BCCB@QP AF>OOEB> IBD
M>FK >OQEO>IDF> AFWWFKBPP FK@OB>PBAPTB>QFKD
EB>A>@EB OBPMFO>QLOV AFPLOABO >@KB ?OB>PQ
M>FK DVKB@LJ>PQF> MOROFQRP PHFKAFPLOABO QBP¦
QF@RI>OM>FK MOLPQ>QBAFPLOABO QEBOHKLTK>A¦
SBOPB AORD OB>@QFLKP LC QOB>QJBKQP @LKQ>FK¦
FKD QBPQLPQBOLKB >OB O>OB @>PBP LC MLIV@VQEB¦
JF> TBFDEQ D>FK BIB@QOLIVQB @E>KDBP JRP@IB
@O>JMP KBOSLRPKBPP ELPQFIFQV ABMOBPPFLK
PIBBM>MKB> FKSBOVO>OB@>PBPG>RKAF@B>KAIFS¦
BO¦CRK@QFLK¦QBPQ>?KLOJ>IFQFBP S>OFLRPPHFKOB¦
>@QFLKP FK@IRAFKD >@KB PB?LOOEB> >KA ?>IA¦
FKD IF?FAL @E>KDBP FK@OB>PBA COBNRBK@V LC
BOB@QFLKP MBOPFPQBKQ M>FKCRI BOB@QFLKP ªMOF>¦
MFPJ« OB>QJBKQTFQEEFDEALPBPLC QBPQLPQBO¦
LKB MOBM>O>QFLKP @LJJLKIV OBSBOPF?IV FKQBO¦
ORMQP LO OBAR@BP PMBOJ>QLDBKBPFP QEBOB?V OB¦
AR@FKD QEB PFWB LC QEB QBPQF@IBP EFDE¦ALPBA LO
ILKD¦QBOJ>AJFKFPQO>QFLKLC QBPQLPQBOLKBL@@>¦
PFLK>IIVFK@OB>PBPQEBL@@ROOBK@BPLC T>QBOOB¦
QBKQFLK >KA BABJ> ROFK>OV L?PQOR@QFLK MOLP¦
Q>QB @>K@BOª>IQELRDE A>Q> LK MOLPQ>QB @>K@BO
OFPH FK >PPL@F>QFLK TFQE QBPQLPQBOLKB QEBO>MV
>OBFK@LK@IRPFSB«
K MOBMR?BOQ>I¥MR?BOQ>I ?LVP QBPQLPQBOLKB ?B¦
PFABP J>P@RIFKFW>QFLK @>K @>RPB >@@BIBO>Q¦
BA DOLTQE >KA ?LKB J>QRO>QFLK >KA MOBJ>¦
QROBBMFMEVPB>I@ILPROB QEBOB?VOBAR@FKDCFK>I
EBFDEQ EB>MMB>O>K@BLC @LJJLK>@KBE>PQL
?BBUMB@QBA
OB@>RQFLKP
B?FALJFDEQOBPRIQFK>MLPFQFSBCFKAFKDFKALM¦
FKDQBPQP IABOM>QFBKQPQOB>QBATFQE>KAOLDBKP
J>V?B>Q>KFK@OB>PBAOFPHCLOQEBABSBILMJBKQ
LC MOLPQ>QF@EVMBOMI>PF> >O@FKLJ>LC QEBMOLP¦
Q>QB E>P QL ?B BU@IRABA ?BCLOB PQ>OQFKD QOB>Q¦
JBKQ TFQE QBPQLPQBOLKB MOBM>O>QFLKP BDRI>O
BU>JFK>QFLKP LC QEB MOLPQ>QB >OB OB@LJJBKA¦
BA BJLDIL?FK >KA E>BJ>QL@OFQ PELRIA ?B
@EB@HBA MBOFLAF@>IIV FK M>QFBKQP LK ILKD¦QBOJ
>KAOLDBKQOB>QJBKQQLABQB@Q@>PBPLC MLIV@V¦
QEBJF> KO>OB@>PBP ?BKFDKIFSBOQRJLOP >KA
BSBKJLOBO>OBIV J>IFDK>KQIFSBOQRJLOPE>SB
?BBK OBMLOQBA FK RPBOP LC QBPQLPQBOLKB @LJ¦
MLRKAP K FPLI>QBA @>PBP QEBPB QRJLOP E>SB
IBAQLIFCB¦QEOB>QBKFKDFKQO>¦>?ALJFK>IEBJLO¦
OE>DBP EBM>QF@ QRJLO PELRIA ?B @LKPFABOBA
FKQEBAFCCBOBKQF>IAF>DKLPFPTEBKPBSBOBRMMBO
>?ALJFK>I M>FK IFSBO BKI>ODBJBKQ LO PFDKP LC
FKQO>¦>?ALJFK>IEBJLOOE>DBL@@ROFKJBKRP¦
FKDB?FAL >QFBKQPMOBAFPMLPBAQLBABJ> M>¦
QFBKQP TEL E>SB E>A BIBS>QBA ?ILLA MOBPPROB
AFPQRO?>K@B FK OBK>I CRK@QFLK BMFIBMPV LO JF¦
DO>FKB PELRIA ?B @ILPBIV JLKFQLOBA EB MOLA¦
R@QJ>VBIBS>QB?ILLAMOBPPROB>KAFPKLQOB@¦
LJJBKABACLOM>QFBKQPTFQE@>OAF>@FKPRCCF@FBK¦
@V OBBUFPQFKDPIBBM>MKB>J>V?BMLQBKQF>QBA
B?FALE>PQL?BRPBATFQE@>RQFLKFKM>QFBKQP
TFQE EVMBO@>I@BJF> ARB QL ?LKB JBQ>PQ>PBP
BORJ@>I@FRJ@LK@BKQO>QFLKPE>SBQL?BJLK¦
FQLOBA OBDRI>OIV FK QEBPB M>QFBKQP KAOLDBKP
>OBKLQPRFQ>?IBCLOBKE>K@FKDJRP@RI>OABSBI¦
LMJBKQFKEB>IQEVFKAFSFAR>IPLOCLOFK@OB>PFKD
MEVPF@>I>?FIFQV
LPLILDV>KAJBQELALC >AJFKFPQO>QFLK
B?FAL FP FKGB@QBA BSBOV QL TBBHP
KGB@QFLKPFKQEBPBFKQBOS>IPIB>AQL>KAJ>FK¦
Q>FK QBPQLPQBOLKB IBSBIP FK QEB MEVPFLILDF@>I
O>KDB>KAALKLQIB>AQL>@@RJRI>QFLK B?FAL
FPPQOF@QIVCLOFKQO>JRP@RI>OFKGB@QFLK>KAJRPQ
?BFKGB@QBASBOVPILTIV MB@F>I@>OBJRPQ?BDFS¦
BKQL>SLFAFKQO>S>P@RI>OFKGB@QFLK EBCFOPQFK¦
GB@QFLKFKQBOS>IJ>V?BOBAR@BAQL>JFKFJRJ
LC TBBHP FQEQEFPIL>AFKDALPB PQB>AV¦PQ>QB
IBSBIPTFII?BOB>@EBANRF@HIV
MB@F>IT>OKFKDP
EBRPBLC QEBMOLAR@QFKMOBMR?BOQ>I@EFIAOBK
FPKLQOB@LJJBKABA KRK>SLFA>?IB@>PBPQEB
QOB>QJBKQ PELRIA ?B @LKAR@QBA RKABO QEB PR¦
MBOSFPFLK LC QEB AL@QLO PMB@F>IFWBA FK MBAF>QOF@
BKAL@OFKLILDV B?FAL FP KLQ FKAF@>QBA CLO RPB
FKTLJBK>KAJRPQKLQ?BRPBAFKMOBDK>KQLO
I>@Q>QFKDTLJBK
IB>PBOBCBOQLQEBRJJ>OVLC OLAR@QE>O>@¦
QBOFPQF@PCLOJLOBABQ>FIBAFKCLOJ>QFLK LOCRO¦
QEBOABQ>FIP@LKQ>@QVLROIL@>I@EBOFKDLOD>KF¦
P>QFLK >QBLC MOBM>O>QFLKLC
RIV
>QBLC MOBM>O>QFLKLC >A @QL?BO
ASBOPBOB>@QFLKP@>K?BOBMLOQBAQL
óA>Q>>K>DBJBKQµP@EBOFKDAB
@EBOFKD BOIFK BOJ>KV
KAOLILDV
SCIENTIFIC PROGRAM
V-1
13.00 - 15.00
Zeremoniensaal
Chairs:
David Ralph, United Kingdom
Edoardo Austoni, Italy
V-01-01
Glans excision and skin grafting for
penile cancer
Suks Minhas, United Kingdom
V-01-02
Gender reassignment surgery procedures
Michael Sohn, Germany
V-01-03
Augmentation Phalloplasty / Soft
prosthesis and albugineal incision
V-01-04
3 piece inflatable penile implant
procedures
V-01-05
Nesbit or grafting
V-01-06
Grafting or Nesbit
V-01-07
Cavernous nerve stimulator and
radical prostatectomy
V-01-08
Management of the epispadias
penis
V-01-09
Enlargement of the penis using intexen: A personal technique
Piero Letizia, Italy
V-01-10
Original space maintainer device in
penile lengthening: A new technique
Piero Letizia, Italy
D-1
Debate
15.00 - 16.00
Zeremoniensaal
The JSM Debate - Chronic dosing of PDE5 inhibitors should become the norm as such treatment
improves erectile, heart and endothelial health
Chair:
Irwin Goldstein, USA
ProSpeaker:
ConSpeaker:
S-1
Graham Jackson, United Kingdom
Francesco Montorsi, Italy (tbc)
John Dean, United Kingdom
Yoram Vardi, Israel
Satellite Symposium
16.00 - 17.00
Festsaal
Testosterone Therapy: New Developments in
Sexual Medicine
Chairs:
Jacques Buvat, France
Eugen Plas, Austria
S-01-01
Symptoms and prevalence of lateonset hypogonadism and relevance
for sexual medicine
Eugen Plas, Austria
S-01-02
Development of the metabolic
syndrome in relation to male hypogonadism
Armin Heufelder, Germany
S-01-03
Is there a link between ED, hypogonadism and risk factors of the metabolic syndrome?
Ian Eardley, United Kingdom
S-01-04
Safety, efficacy and sexual benefits
of long-acting, injectable testosterone
undecanoate (Nebido (R)) in men
with low testosterone levels
Herrmann Behre, Germany
S-01-05
Co-therapy testosterone-PDE 5 inhibitors in hypogonadal ED patients:
Rationale and perspectives
sponsored by an educational grant of Schering AG.
23
24
SCIENTIFIC PROGRAM
S-2
Satellite Symposium
17.15 - 18.15
Zeremoniensaal
Clinical & Scientific Advances in PE: From
Diagnosis to Drug Treatment
Chair:
S-02-01
Factors affecting the diagnosis and
impact of PE
Chris McMahon, Australia
S-02-02
The mode of action and clinical efficacy of dapoxetine in PE
S-02-03
The evaluation of withdrawal effect
with dapoxetine in the treatment of
PE and its affect on distress and
interpersonal difficulty:
Richard Casey, Canada
S-02-04
The tolerability and long-term efficacy of dapoxetine in PE
Opening Ceremony
18.15 - 19.30
Festsaal
followed by a Welcome Reception on the ground
floor of the Hofburg from 19.30 to 20.30 h.
sponsered by an educational grant of Janssen-Cilag
Pharmaceutica NV
Technical Exhibition
A major technical exhibition welcomes you in the Exhibition Area on the first ground of the Vienna
Hofburg.
Opening hours
Wednesdy, 6, December 2006
09.00 - 17.00 h
09.00 - 17.00 h
09.00 - 12.30 h
Poster Exhibition
The poster exhibition takes place in the Gardehalle I and II on the ground floor of the Vienna Hofburg.
Opening hours
Wednesdy, 6, December 2006
09.00 - 17.30 h
09.00 - 17.30 h
09.00 - 12.30 h
SCIENTIFIC PROGRAM
ML-1
P-1
Master Lecture
08.00 - 08.30
Festsaal
The ISSM Lecture
Chair:
ML-01-01
ML-2
Is there a relation between hypogonadism and the metabolic syndrome?
Ridwan Shabsigh, USA
ML-3
P-01-001
Assessment of the relational factor
in male patients consulting for sexual
dysfunction: The concept of couple
sexual dysfunction
L. Petrone, E. Mannucci, A. Magini,
F. Lotti, V. Ricca, V. Chiarini, G. Forti,
M. Maggi
P-01-002
The role of the sexologist in sexual
medicine
Elena Longhi, Italy
A. Salonia, R. Colombo, G. Zanni,
C. Lania, A. Briganti, P. Rigatti,
F. Montorsi
P-01-003
Factors that contribute to sexual
satisfaction
Antonio Fernandez Lozano, Spain
I. Sotolongo Vergo, E. Ruiz Castañe
P-01-004
Community pharmacists’s views on
sexual dysfunction
Stamtis
Papacharitou,
Greece
E. Nakopoulou, E. Katsohi, D. Kouvelas,
D. Hatzichristou
P-01-005
Testosterone
regulates
rhoa/
rho-kinase signalling in two distinct
animal models of chemical diabetes
Linda Vignozzi, Italy
A. Morelli, S. Filippi, R. Mancina,
M. Luconi, S. Ambrosini, G. B. Vannelli,
G. Forti, M. Maggi
P-01-006
Estrogens regulate epididymal contractility through rhoa/rho-kinase
signalling
Sandra Filippi, Italy
A. Morelli, L. Vignozzi, R. Mancina,
G. Forti, M. Maggi
P-01-007
Androtest: A structured interview
for the screening of hypogonadism
in patients with sexual dysfunction
L. Petrone, E. Mannucci, A. D. Fisher,
G. Balercia, V. Chiarini, G. Forti, M. Maggi
Hyposexual desire disorder - Attitudes to diagnosis and treatment
Anita Clayton, USA
Master Lecture
09.00 - 09.30
Festsaal
Affect, anthropology and pharmacotherapy Culprits in HIV-related FSD
Chair:
Ellids Kristensen, Denmark
Speaker:
David Goldmeier, United Kingdom
B-1
Best Papers
10.00 - 11.30
Festsaal
Chairs:
Zeremoniensaal
Hormones and Sexuality
Chairs:
Eginhard Waldkirch, Germany
Festsaal
The ISSWSH Lecture
Chair:
Yoram Vardi, Israel
ML-02-01
10.00 - 11.30
Master Lecture
08.30 - 09.00
Podium Session
25
26
SCIENTIFIC PROGRAM
P-01-008
Positive impact of a new educational program to optimize treatment
with sildenafil
Gerry Brock, Canada
S. Carrier, R. Casey, J.-E. Tarride,
P. D’Angelo, S. Elliott, H. Dugre,
C. Rousseau, I. Defoy
P-01-009
Safety and tolerability of Transdermal Testosterone Patch (TTP) in
surgically menopausal women receiving oral or transdermal estrogen
over 36 months of therapy
L. Nachtigall, USA
P. Casson, J. Lucas, C. Melson,
V. Schofield
P-01-010
MP-1
Comparison of men and women of
the BDSM community in Portugal:
An internet based study
Patricia Pascoal, Portugal
R. Rui Henriques, N. Monteiro Pereira
10.00 - 11.30
Forum
Chairs:
Daniel Richardson, United Kingdom
MP-01-069 In vivo neuronal activity in the
hypothalamus varies with oestrus
cycle in female rats: Baseline conditions and effects of dopamine
receptor agonism
Natalie Richards, United Kingdom
K. Allers
MP-01-070 Pharmacological differences of neuropeptides between rabbit vaginal
smooth muscle and vaginal arteries
in vitro
Karen Aughton, United Kingdom
K. Hamilton-Smith, C. Wayman,
M. Jackson
MP-01-071 Is sexual function different in obese
women?
Baris Altay, Turkey
B. Turna, U. Aliyeva, O. Kaan,
E. Muktharov, S. Cetinkalp, C. Yilmaz,
B. Semerci
MP-01-072 Effects of intra-nasally administered
testosterone on sexual behavior in
female capuchin monkeys (Cebus
apella)
Bianca Topic, Germany
M. C. Tavares, C. Tomaz, J. P. Huston,
C. Mattern
MP-01-073 Effects of hypoactive sexual desire
disorder treatment on relationships
Dianne Felblinger, USA
P. E. Koochaki, K. Wekselman
MP-01-074 To evaluate female sexual function
after colpoperineoplasty
Min Her, Republic of Korea
J. Kim, E. Kim, J. Lee, H. Cho
MP-01-075 Prevalence of female sexual dysfunction in Germany Results of the
crossover-study
„The
Cologne
20.000 community survey“
Joanna Beate Korda, Germany
M. Braun, H. Christ, M. Hellmich,
U. Engelmann
MP-01-076 Rethinking desire: Prevalence and
correlates of desire discordance in
the Nurses Sexuality Study
Michael Sand, Germany
MP-01-077 Nocturnal Vaginal pH-Meter: Can it
be a new screening method for
female sexual dysfunction
Levent Peskircioglu, Turkey
M. R. Goren, A. Dirim, H. Ozkardes
MP-01-078 Development and validation of a
new screening tool for hypoactive
sexual desire disorder: The Brief
Profile of Female Sexual Function©
(B-PFSF©)
S. Golombok, United Kingdom
L. Derogatis, C. Rodenberg, P. Koochaki,
S. Schmitt, J. Rust
SCIENTIFIC PROGRAM
MP-01-079 Development and initial validation
of the Female Assessment of Male
Erectile Dysfunction Detection Scale
(FAME): Report of a pilot study
Eusebio Rubio-Aurioles, Mexico
I. Arango de Montis, N. T. Roccatti,
M. Sand
MP-01-080 Presence of a sexual dysfunction
may not always affect women’s
satisfaction from their sexual function
Fotini Ferenidou, Greece
V. Kapoteli, K. Moysidis, I. Koutsogiannis, A. Giakoumelos, D. Hatzichristou
MP-01-081 Effect of Topical Misoprostole on
Clitoral Hemodynamics
Levent Peskircioglu, Turkey
M. R. Goren, S. R. Erdem, A. I. Oguzulgen, H. Ozkardes
MP-01-082 Effects of the dopamine receptor
agonist, apomorphine on unconditioned sexual incentive motivation
in ovariectomised female rats
Tony Hawcock, United Kingdom
L. Turner, T. Dawkins, N. Edmunds
MP-01-083 ‘Receptivity score’: An improved
measure of sexual arousal in the rat
Tony Hawcock, United Kingdom
S. Katechia, N. Edmunds
C-1
10.00 - 11.30
Prinz-Eugen-Saal
How implant a penile prosthesis
Chair:
C-01-01
Couple counselling and patient
selection
Amanda Spillings, United Kingdom
C-01-02
Penile prosthesis - selecting prothesis
and surgical tricks
C-01-03
Result and long-time follow-up
Mariano Rossello Barbara, Spain
C-01-04
Penile prosthesis complications how to manage
CP-1
11.30 - 12.00
Festsaal
Hypogonadism and Erectile Dysfunction - What
to treat first?
Chair:
CP-01-01
Hypogonadism
Mario Maggi, Italy
CP-01-02
ML-4
Master Lecture
11.30 - 12.00
Zeremoniensaal
Can we evidence improvement in quality of life
when successfully treating ED?
Chair:
John Pryor, United Kingdom
Speaker:
Axel Fugl-Meyer, Sweden
S-3
Satellite Symposium
12.30 - 13.30
Festsaal
Connecting the Dots in ED Treatment: Erectile
Function & Satisfaction
Chair:
John Mulhall, USA
S-03-01
Welcome/Introductions
John Mulhall, USA
S-03-01
Treatment to Goal: Monitoring
Response to ED Treatment
John Mulhall, USA
S-03-02
Hardness of Erection as a Treatment
Goal: Recent Clinical Evidence
Klaus-Peter Jünemann, Germany
S-03-03
Connecting the Dots - Implications
of the Consensus for Patients,
Partners, and Physicians
Michael Kirby, United Kingdom
S-03-04
Closing Remarks/Question & Answer
John Mulhall, USA
sponsored by an educational grant of Pfizer Inc.
27
28
SCIENTIFIC PROGRAM
I-1
Interactive Session
13.30 - 15.00
P-02-015
Risk of severe erectile dysfunction is
higher in older, overweight men
Serge Carrier, Canada
A. Morales, I. Defoy
P-02-016
Prevalence of neuropathic disturbances and their predictive value for
erectile dysfunction in diabetic men
Zdravko Kamenov, Bulgaria
V. Christov, T. Yankova
P-02-017
In vivo electrophysiology in the
paraventricular nucleus: Correlations with erectile activity
Kelly Allers, United Kingdom
N. Richards, C. Wayman
P-02-018
Sexual life quality of 10.161 subjects
over 40 years old: Partial results
Carmita Abdo, Brazil
J. A. Abdo, M. E. Caetano
Best Papers
13.30 - 15.00
Zeremoniensaal
Surgery / Peyronie’s
Chairs:
Juan Ignacio Martinez-Salamanca, USA
P-2
Prothrombotic markers predict the
presence of erectile dysfunction
Charalambos Vlachopoulos, Greece
K.
Aznaouridis,
C.
Vasiliadou,
K. Rokkas, N. Ioakeimidis, I. Dima,
A. Askitis, C. Stefanadis
Festsaal
Chair:
Kevan Wylie, United Kingdom
Panel:
Loukas Athanasiadis, Greece
Lori Boul, United Kingdom
Brian Danes, United Kingdom
Ruth Hallam, United Kingdom
Sue Nicol, United Kingdom
B-2
P-02-014
Podium Session
13.30 - 15.00
Forum
Pathophysiology of sexual dysfunctions
Chairs:
Javier Angulo Frutos, Spain
Andreas Jungwirth, Austria
P-02-011
P-02-012
P-02-013
Isolated hypertriglyceridaemia and
erectile dysfunction: Is there a significant correlation?
Sudhanshu Chitale, United Kingdom
S. Irving
The metabolic syndrome and associated sexual dysfunction: Psychobiological correlates
E. Mannucci, L. Petrone, R. Mansani,
C. Schulman, G. Balercia, V. Chiarini,
G. Forti, M. Maggi
Erectile dysfunction is related to
arterial stiffness and markers of
systemic vascular inflammation and
endothelial function in patients
with metabolic syndrome
Konstantinos Rokkas, Greece
C. Vlachopoulos, N. Ioakeimidis,
K. Aznaouridis, C. Vasiliadou, D. Tsekoura,
K. Baou, A. Askitis, C. Stefanadis
C-2
13.30 - 15.00
Prinz-Eugen-Saal
Testosterone Replacement
Chair:
C-02-01
Epidemiology and diagnosis challenges
C-02-02
Metabolic consequences of androgen
deficiency and benefits of treatment
Geoffrey Hackett, United Kingdom
C-02-03
Testosterone and the prostate
Claude Schulman, Belgium
C-02-04
Selecting a treatment regime
Treatment in practice: Case discussions
Faculty and The Audience
SCIENTIFIC PROGRAM
R-1
Round Table
15.30 - 17.00
Zeremoniensaal
The Ageing Couple
Chair:
R-01-01
Menopause - effect on couples sexual
function when treating ED
R-01-02
Male menopause - fact or fiction?
R-01-03
ED and treatment - impact on couples sexual function
R-01-04
Treating the ageing couple
MP-2
15.30 - 17.00
Forum
Pharmacology
Chairs:
Emre Akkus, Turkey
Konstantinos Hatzimouratidis, Greece
MP-02-084 A comparison of vardenafil and sildenafil: Treatment satisfaction
among men with erectile dysfunction
and cardiovascular risk factors, and
their partners
H. Porst, I. Eardley, I. Goldstein
MP-02-085 Efficacy of tadalafil dosed once a
day to treat erectile dysfunction in
men with comorbid moderate or
severe
lower
urinary
tract
symptoms secondary to benign prostatic hyperplasia
C. P. Steidle, J. M. Kaufman, R. A. Feldman, M. C. Gittelman, K.-E. Andersson,
K. Loughney, J. W. Hirman, B. Denes
MP-02-086 Erection hardness and quality correlate with erectile function, emotional well-being, and treatment satisfaction: Double-blind, placebo-controlled multinational trial of Viagra®
(Sildenafil Citrate)
Andrzej Depko, Poland
A. Kadioglu, W. Grohmann, I. Levinson,
M. Carlsson, S. Collins
MP-02-087 Clinical Experience with Invicorpâ at
Good Hope Hospital ED Clinic 19962006
F. Larsen
MP-02-088 Vardenafil improves sexual function
in men with erectile dysfunction
and their female partners
William Fisher, Canada
R. Rosen, M. Mollen, G. Brock,
G. Karlin, P. Pommerville, I. Goldstein,
K. Bangerter, Z. Herman-Gnjidic,
T. Taylor, L. Derogatis
MP-02-089 Improvement in erection hardness
for men with milder erectile dysfunction is associated with improvements in measures of psychosocial
well-being
W. Grohmann, A. Depko, I. Levinson,
M. Carlsson
MP-02-090 Therapeutic effect of combination
of alagebrium and sildenafil on
erectile function in diabetic rats
Mustafa Faruk Usta, Turkey
G. Sagdic, N. Gurbuz, A. Sanli,
R. Gurkan, A. Baykal
MP-02-091 Efficacy of sildenafil citrate treatment after re-instruction in normogonadal patients with sildenafil failed
patients
Murad Basar, Turkey
A. Atan, A. Tuncel, D. Tuglu
29
30
SCIENTIFIC PROGRAM
MP-02-092 A normal endothelium increases the
therapeutic role of Tadalafil in vasculogenic erectile dysfunction
Mario Mancini, Italy
M. Guazzi, F. Nerva, G. Contalbi,
G. M. Colpi
MP-02-093 Vardenafil and Alfuzosin polypharmacotherapy for erectile dysfunction
Vipan Bhatia, United Arab Emirates
MP-02-094 Phosphodiesterase type 5 inhibitornaive men with erectile dysfunction
can achieve completely hard and
fully functional erections with
Viagra® (Sildenafil Citrate)
Suzanne Collins, USA
V. Stecher, H. Wang
MP-02-095 Vardenafil improves erectile function
in men and treatment satisfaction in
couples affected by erectile dysfunction previously untreated with
pde5 inhibitors
David Edwards, United Kingdom
G. Hackett, O. Collins, J. Curram
MP-02-096 Dapoxetine has no significant QT
interval or other electrocardiographic effects in healthy men
Nishit Modi, USA
P. Staehr, M. Dresser, D. Rivas
MP-02-097 Comparison the efficacies of sildenafil only to the sildenafil plus
testosterone
treatment
after
re-instruction in sildenafil failed
normogonadal patients
Ali Atan, Turkey
M. M. Basar, A. Tuncel, D. Tuglu
MP-02-098 Factors influencing continuation of
tadalafil treatment for erectile dysfunction at 6 months: Results from
the DETECT study
Stefan Arver, Sweden
P. Perimenis, H. Heidler, T. Roumeguere,
M. Belger
C-3
15.30 - 17.00
Prinz-Eugen-Saal
Basics in Ejaculatory Disorders
Chair:
C-03-01
Symptoms, definitions and classification
C-03-02
Epidemiology and diagnosis
Axel Fugl-Meyer, Sweden
C-03-03
Non pharmacological perspectives in
the treatment of ejaculatory disorders
Tricia Barnes, United Kingdom
C-03-04
Pharmacological treatment options
C-03-05
Acquired PE due to thyroid dysfunction and prostatitis
S-4
Satellite Symposium
17.00 - 18.30
Integrating Partners into
Unrealistic or Mandatory?
Festsaal
ED
Treatment:
S-04-01
Welcome and introduction
S-04-02
Female Perspectives on Sexual Health
S-04-03
Understanding the Interactive
Nature of ED: Female Perceptions
S-04-04
Clinical Review of Vardenafil:
Applications for Couple Interaction
S-04-05
Question and Answer, Summary
sponsored by an educational grant of Bayer
HealthCare AG
ESSM Business Meeting
18.30 - 19.30
For members only
Zeremoniensaal
SCIENTIFIC PROGRAM
ML-5
Master Lecture
08.00 - 08.30
R-2
Festsaal
Round Table
10.00 - 11.30
Festsaal
The ESAU Lecture
Chair:
Vincenzo Mirone, Italy
More Hot Topics with PDE5 Inhibitors
Chair:
Antonio Martin Morales, Spain
ML-05-01
R-02-01
Non-prescribed use of PDE5 inhibitors
R-02-02
Are there neurovascular protective
effects of PDE5 inhibitors?
John Mulhall, USA
R-02-03
PDE5 and urogenital functions unanswered questions and future
perspectives
ML-6
Testosterone Deficiency: Risks and
Benefits of Testosterone Treatment
Claude Schulman, Belgium
Master Lecture
08.30 - 09.00
Festsaal
The SMSNA Lecture
Chair:
ML-06-01
Peyronie’s Disease
Wayne Hellstrom, USA
P-3
Podium Session
10.00 - 11.30
ML-7
09.00 - 09.30
Festsaal
The ESSM Award Lecture
Chair:
ML-07-01
S-5
Zeremoniensaal
Master Lecture
Chairs:
Yoram Vardi, Israel
Christina Damsted Petersen, Denmark
P-03-019
Sexual distress in Danish women
with type I and type II diabetes
E. Kristensen, J. Vibe-Petersen,
L. Behrend, E. Hommel, L. F. Eplov
P-03-020
Female sexual function after surgery for stress urinary incontinence:
Transobturator Suburethral Tape
(TOT) versus Tension-free Vaginal
Tape Obturator (TVT-O)
Henk Willem Elzevier, Netherlands
H. Putter, R. C. M. Pelger, G. A. B Lycklama a Nijeholt
P-03-021
Review of Potential Role of
Bremelanotide (PT-141) in the
Treatment of Female Sexual Dysfunction
Michael A. Perelman, USA
FSD - what have we learned from a
decade of clinical research?
Andrea Salonia, Italy
Satellite Symposium
09.30 - 10.00
Zeremoniensaal
A Critical Overview of Current Guidelines in LOH
Chair:
Speaker:
sponsored by an educational grant of
31
32
SCIENTIFIC PROGRAM
P-03-022
Nasally applied testosterone rapidly
increases the amygdala response to
emotional stimuli in middle-aged
women
Guido van Wingen, The Netherlands
S. Zylicz, S. Pieters, K. M. Petersson,
C. Mattern, R. J. Verkes, G. Fernandez
P-03-023
The Effect of a testosterone transdermal patch on hypoactive sexual
desire disorder in postmenopausal
women not receiving systemic
estrogen therapy, The APHRODITE
study
J. Studd, United Kingdom
C. Bouchard, R. Kroll, H. Koch, B. von
Schoultz, S. Davis
P-03-024
Sexual problems in the transition to
menopause
Judith Alder, Switzerland
E. Leiser, J. Marti, J. Bitzer
P-03-025
Epidemiology of dyspareunia in
sexually active pre-menopausal
women: Relationship to contraceptives
K. Fugl-Meyer, A. Fugl-Meyer
P-03-026
The prevalence of female sexual
dysfunction in partners of men with
premature ejaculation
Kevin Hobbs, United Kingdom
T. Symonds, L. Abrahams, K. May,
M. Morris
P-03-027
Endorsement of models of female
sexual response and correlation
with FSFI scores in a sample of registered nurses: The Nurses Sexuality
Study
P-03-028
Hypothalamic neuropeptides have
functional receptors in the rat spinal
cord (l4-s1) which may modulate
female sexual function
Lesley Wilson, United Kingdom
C. Wayman, M. Jackson
MP-3
10.00 - 11.30
Forum
Basic Science - Physiology and Pathophysiology
Chairs:
Ulf Simonsen, Denmark
MP-03-099 Expression of cyclic AMP-dependent
protein kinase-1 isoforms in human
cavernous arteries (HCA) and corpus
cavernosum (HCC): Relation to vasoactive intestinal polypeptide-containing nerves and PDE4
S. Ueckert, K. Langnäse, K. Richter,
M. Sohn, U. Jonas, G. Wolf,
K.-E. Andersson, C. G. Stief, P. Hedlund
MP-03-100 Relationship between well-being
and erectile function and autonomic
variables in male with/without
sexual dysfunction
Tolga Dogru, Turkey
O. M. Kocak, M. M. Basar, N. ErberkOzen, E. Batislam
MP-03-101 The role of rho/rhokinase pathway
in serotonin-induced contraction in
diabetic and nondiabetic human
corpus cavernosum
Nergis Murat, Turkey
B. C. Burak, O. Demir, S. Gidener,
A. Esen
MP-03-102 Increased levels of endothelin-1 as a
marker of a generalized vascular
disease manifested by vasculogenic
erectile dysfunction
C. Vlachopoulos, N. Ioakeimidis,
C. Vasiliadou, I. Dima, G. Antoniou,
MP-03-103 Correlation of penile Doppler findings of arterial flow and severity
of coronary artery disease
K. Rokkas, N. Ioakeimidis, C. Aggeli,
G. Roussakis, D. Soulis, A. Askitis,
A. Michailides, C. Stefanadis
SCIENTIFIC PROGRAM
MP-03-104 Erectile dysfunction is associated
with increased aortic stiffness in
patients with and without coronary
artery disease
N. Ioakeimidis, K. Rokkas, A. Tsokanis,
D. Adamopoulos, P. Xaplanteris,
C. Fassoulakis, C. Stefanadis
MP-03-105 Electrical activity in the ventromedial nucleus in vitro predicts lordosis
behaviour
Clair Booth, United Kingdom
C. Wayman, M. Jackson
MP-03-106 Exacerbated pressor response regulated by daily treatment with sildenafil in an animal model of metabolic syndrome
Delphine Behr-Roussel, France
A. Oudot, S. Compagnie, D. Gorny,
O. Le Coz, J. Bernabé, C. Wayman,
L. Alexandre, F. Giuliano
MP-03-107 Investigation of TGF- Beta 1 levels in
patients with Peyronie’s Disease
(PD)
Evsey Mazo, Russia
L. Ivanchenko, M. Moufagued
MP-03-108 Expression of messenger rna
(mRNA) encoding for phosphodiesterase (PDE) isoenzymes in human
female genital tissues
P. Ellinghaus, K. Albrecht, U. Jonas
MP-03-109 Sexual and erectile function after
treatment of testicular cancer
Jakob Lackner, Austria
I. Märk, G. Schatzl, C. Kratzik,
M. Marberger
MP-03-110 Erectile dysfunction may predict
coronary artery disease: Relationship with coronary artery calcium
scoring and erectile dysfunction
severity
Olider Yaman, Turkey
O. Gulpinar, T. Hasan, C. Ozdol,
S.F. Ertas, E. Ozgenci
MP-03-111 The quality of erection questionnaire
for the assessment of erection quality, hardness, and duration in men
with erectile dysfunction
Vera Stecher, USA
S. Collins, H. Wang
MP-03-112 Factors associated to bother from
sexual problems: Results from the
hoppes study
Paraskevi-Sofia Kirana, Greece
M. Fridakis, K. Moisidis, R. Rosen,
J. McKinlay, D. Hatzichristou
MP-03-113 Influence of concomitant diseases
on the sexual quality of life of
patients with erectile dysfunction
and their partners
Pedro R. Gutierrez, Spain
M. Mas, P. Hernandez, E. J. Sanz,
O. Cardenosa, A. Munoz, M. Artes
C-4
10.00 - 11.30
Prinz-Eugen-Saal
Psychotherapies in Premature Ejaculation
Chair:
Tricia Barnes, United Kingdom
C-04-01
Cognitive Behavioural Approaches
in the Treatment of Premature
Ejaculation
Mehmet Sungur, UK
C-04-02
Treatment Resistant cases of Premature Ejaculation : A Psychoanalytic
Approach
Marie Chevret Measson, France
C-04-03
An
Integrative
Approach
to
Premature Ejaculation - Emotional
and Relationship Perspectives
Chiara Simonelli, Italy
CP-2
11.30 - 12.00
Festsaal
PDE5 inhibitors in Patients with Premature
Ejaculation but not ED?
Chair:
Hans Hedlund, Norway
Pro-Speaker: Alberto Briganti, Italy
Con-Speaker: Marcel D. Waldinger, The Netherlands
33
34
SCIENTIFIC PROGRAM
HS-1
History Session
11.30 - 12.00
P-4
Zeremoniensaal
Freud to Steinach - From the History of Sexual
Medicine in Vienna
Chair:
Dirk Schultheiss, Germany
S-6
13.30 - 15.00
From Clinical Study
Optimizing ED Therapy
P-04-029
Safety and efficacy of orally inhaled
apomorphine (VR004) in the treatment of erectile dysfunction
Alan Riley, United Kingdom
F. Morgan, M. Main, M. Newton,
J. Kirkpatrick
P-04-030
Increased erection hardness in men
treated with flexible-dose Viagra®
(Sildenafil Citrate) in a double-blind,
placebo-controlled multinational
trial with open-label extension
W. Grohmann, A. Depko, I. Levinson,
F. Sun, S. Collins
P-04-031
Daily tadalafil improves endothelial
and erectile function in men with
systemic sclerosis
M. Proietti, R. Bruzziches, C. Rossi,
E. A. Greco, C. Letizia, F. Salsano, G. Spera
P-04-032
Daily treatment with sildenafil
reverses endothelial dysfunction
and oxidative stress in an animal
model of metabolic syndrome
Delphine Behr-Roussel, France
A. Oudot, S. Caisey, O. Le Coz,
D. Gorny, J. Bernabe, C. Wayman,
L. Alexandre, F. Giuliano
P-04-033
Differential effects of 2-week treatment with atorvastatin or elocalcitol,
rhoa/rho-kinase signalling modulators, on erectile function and sildenafil responsiveness in spontaneously hypertensive rats
Annamaria Morelli, Italy
X.-H. Zhang, S. Filippi, L. Vignozzi,
S. Mungai, L. Adorini, M. Maggi
Festsaal
to
Clinical
Practice:
Welcome
Gerald Brock, Canada
S-06-01
Clinical studies and observational
studies: Their relative merits for
clinical practice?
Josép Maria Haro, Spain
S-06-02
Comparing efficacy of and preference for Sildenafil Citrate and
Tadalafil
Gerald Brock, Canada
S-06-03
Alternative Dosing Regimens with
Tadalafil in Clinical Studies
David Ralph, UK
Questions and Closing Remarks
sponsored by an educational grant of Lilly ICOS LLC
I-2
Interactive Session
13.30 - 15.00
Festsaal
Chair:
Panel:
Vincenzo Mirone, Italy
Eugen Plas, Austria
Jens Sönksen, Denmark
Ragnar Stien, Norway
Zeremoniensaal
Pharmacology
Chairs:
Eric Wespes, Belgium
Satellite Symposium
12.30 - 13.30
Podium Session
SCIENTIFIC PROGRAM
P-04-034
P-04-035
P-04-036
P-04-038
MP-4
A comparison of vardenafil and sildenafil: Preference among men with
erectile dysfunction and cardiovascular risk factors
E. Rubio-Aurioles, I. Eardley, I. Goldstein
Consistent benefits with vardenafil
regardless of age, prior pde-5 use or
geographical location in men with
erectile dysfunction and their partners: the COUPLES-project
Ray Rosen, USA
W. Fisher, M. Beneke, M. Homering,
T. Evers
Tadalafil administered once a day is
efficacious and well tolerated for
treating erectile dysfunction in men
with diabetes mellitus
Gerry Brock, Canada
J. Buvat, M. Gambla, D. Hatzichristou,
D. Lording, L. Rose, E. R. Aurioles,
G. Spera, S.-Y. Liang, L. Frumkin
Randomized, double-blind, placebocontrolled, at-home study of intranasal bremelanotide (PT-141) in men
with erectile dysfunction with and
without diabetes mellitus
M. Gittelman, N. Zinner, T. Hallam,
R. Harning, D. Dworaczyk, R. Rolleri
13.30 - 15.00
Forum
Surgery, Peyronie’s Disease and Priapism
Chairs:
Suks Minhas, United Kingdom
MP-04-114 A trauma of the penis as an etyological factor of Peyronie disease
Yuriy Gurzhenko, Ukraine
MP-04-115 Geometrical principle in the surgical
treatment of Peyronie’s disease - egydio procedure: Belgrade experience
M. Djordjevic, R. Djinovic, S. Sansalone
MP-04-116 The role of MRI in the management
of ischaemic priapism
Paul Anderson, United Kingdom
C. Allen, S. Minhas, D. Ralph
MP-04-117 Andrologic aspects of the exstrophy-epispadias-complex after functional bladder reconstruction
Anne Ebert, Germany
M. Bals-Pratsch, B. Seifert, W. H. Roesch
MP-04-118 Phalloplasty using of radial forearm
flap with the reimplantation of
distal fragment of penis
Mikhail Sokolschik, Russia
S. Gagarina, Y. Vasiev, R. Petrovich,
I. Sadakova
MP-04-119 The 10 years experience in grafting
corporoplasty Know-how and qualityfactors. Keep spacers patches
Patteo Paradiso, Italy
O. Sedigh, G. L. Milan, M. E. Graziano,
U. Ferrando
MP-04-120 Penile fracture. Differential diagnosis, management and outcome
Jorge Cabral Ribeiro, Portugal
MP-04-121 Emblematic case of penile ventral
deformation (120°) with ED.
Albuginea modeling and straithening with penile Implantation
Omid Sedigh, Italy
M. Paradiso, M. E. Graziano, F. Liberale,
U. Ferrando
MP-04-122 Radial artery urethroplasty in phalloplasty
Christopher Nim, United Kingdom
D. Ralph
MP-04-123 Long term results of primary penile
venous leakage surgery with crural
ligation in men with erectile dysfunction at a single university hospital
Selahittin Cayan, Turkey
D. Acar, E. Akbay
MP-04-124 The use of dermal fillers in Andrology
Giulio Garaffa, United Kingdom
S. Minhas, P. Kell, D. Ralph
35
36
SCIENTIFIC PROGRAM
MP-04-125 Penile enlargement corporoplasty
with prosthetic implant: Original
reconstructive technique for sexual
and erectile dysfunction
A. Cazzaniga, A. Guarneri, A. L. Romano, E. Austoni
MP-04-126 Outcome from penile prostheses
revision surgery
Paul Anderson, United Kingdom
V. Agarwal, F. Soden, D. Ralph,
S. Minhas
MP-04-127 Long term efficacy and patient satisfaction of plication corporoplasty in
congenital penile curvature
Giorgio Franco, Italy
A. Cavaliere, G. Del Vecchio, D. Dente,
N. Almoghalis, F. D’Amico
MP-04-128 Hypoxia-inducible factor-alpha is
elevated in Peyronie’s disease
plaques - hypoxia is an aetiological
factor?
Vineet Agrawal, United Kingdom
P. Munson, S. Minhas, A. Freeman,
D. Ralph
C-5
13.30 - 15.00
B-3
15.30 - 17.00
C-05-01
Anatomy and physiology
Ferdinando Fusco, Italy
C-05-02
Assessment and physical examination
Bert-Jan de Boer, The Netherlands
C-05-03
Treatment
Zeremoniensaal
Chairs:
P-5
Podium Session
15.30 - 17.00
Forum
Chairs:
Juza Chen, Israel
Stefan Arver, Sweden
P-05-039
Dapoxetine acts supraspinally to
inhibit ejaculatory reflex in anaesthetised rats
Pierre Clement, France
J. Bernabe, P. Gengo, P. Denys,
M. Laurin, L. Alexandre, F. Giuliano
P-05-040
Vibratory ejaculation and home
insemination in 140 spinal cord injured
men and their partners
Jens Sönksen, Denmark
D. Löchner-Ernst, D. Ohl
P-05-041
Dapoxetine for the treatment of
premature ejaculation: Low incidence of sexual side effects
J. Pryor, F. Tesfaye
P-05-042
Open pilot studies and a multi-centre, open-label, parallel-group study
of the Sexual Assessment Monitor
(SAM) in patients with premature
ejaculation
W. Dinsmore, Ireland
D. Ralph, P. Kell, K. Wylie, J. Dean,
C. Novak, J. Wyllie, M. Wyllie
P-05-043
Retarded ejaculation: A psycho-physiological approach forassessment
and management in 22 patients
Ronen Rub, Israel
M. Kreizman, J. Chen, P. Hegarty,
N. Erlich
Prinz-Eugen-Saal
Basics in Erectile Dysfunction
Chair:
Best Papers
SCIENTIFIC PROGRAM
P-05-044
P-05-045
P-05-046
P-05-047
P-05-048
Further validation of the newly
developed Premature Ejaculation
Diagnostic Tool
Tara Symonds, United Kingdom
M. Perelman, S. Althof, F. Giuliano,
M. Martin, L. Abraham, A. Crossland,
M. Morris, K. May
TEMPE, a novel aerosol delivery
form of lidocaine-prilocaine for the
treatment of premature ejaculation
Mike Wyllie, United Kingdom
W. Dinsmore, G. Hackett, D. Goldmeier,
M. Waldinger, J. Dean, P. Wright,
M. Callander, K. Wylie, C. Novak,
C. Keywood, P. Heath
Effects of selective phosphodiesterase inhibitors on the contractile
responses of isolated human seminal vesicle tissue
S. Bazrafshan, M. Mayer, U. Jonas,
C. Stief
Does sildenafil alleviate premature
ejaculation - a double blind, placebo
control cross-over study
Juza Chen, Israel
Y. Bar-Yosef, M. Sofer, N. J. Mabjeesh,
A. Greenstein, H. Matzkin
Comparison of sertralin vs. sertralin+PDE5 inhibitors in the treatment
of premature ejaculation
Emre Akkus, Turkey
B. Alici, H. Ozkara, B. Onal, H. Hattat
C-6
15.30 - 17.00
Prinz-Eugen-Saal
Advanced ED Management - from Pharmacotherapy to Penile Implant
Chairs:
C-06-01
Conservative management of the
difficult to treat ED patient
C-06-02
Surgical treatment of the difficult to
treat ED patient
C-06-03
Injection therapies and vacuum
devices
S-7
Satellite Symposium
17.00 - 18.00
Zeremoniensaal
Integrated Management of HSDD. Intrinsa, a
New Therapeutic Option
Chair:
John Dean, UK
S-07-01
Revealing the faces of Hypoactive
Sexual Desire Disorder
Johannes Bitzer, Switzerland
S-07-02
Intrinsa - completing your treatment
choices
Anneliese Schwenkhagen, Germany
sponsored by an educational grant of Procter &
Gamble Pharmaceuticals
37
38
SCIENTIFIC PROGRAM
I-3
Interactive Session
08.00 - 09.30
Podium Session
08.00 - 09.30
Effect of sildenafil administration
on penile hypoxia induced by cavernous neurotomy in the rat
Linda Vignozzi, Italy
A. Morelli, S. Filippi, M. Marini,
G. B. Vannelli, G. Forti, M. Maggi
P-06-054
Low-dose sildenafil improves recovery of erectile function after nervesparing radical prostatectomy
Andreas Bannowsky, Germany
H. Schulze, C. van der Horst,
S. Hautmann, K.-P. Jünemann
P-06-055
A prospective, randomized, placebo-controlled multicentre study on
the effectiveness of oral sildenafil in
preventing postoperative erectile
dysfunction following radical retropubic prostatectomy
Pekka Kunelius, Finland
J. Häkkinen, P. Ohtonen
P-06-056
Long-term follow-up (fu) of intracavernous (ic) injection therapy for
erectile dysfunction (ed)
L. Barbieri, A. Gallina, A. Briganti,
F. Deho, G. Zanni, N. Suardi, F. Pellucchi,
F. Abdullah, P. Rigatti, F. Montorsi
P-06-057
The use of the IIEF-5 questionnaire
for evaluation of erectile dysfunction
following nerve-sparing radical prostatectomy
Maarten Albersen, Belgium
S. Joniau, H. van Poppel, H. Claes
P-06-058
Reconsidering the use of IIEF questionnaire in evaluating the preoperative
erectile function status of patients
undergoing radical prostatectomy
Stefanos Papadoukakis, Germany
D. Kusche, B. Löppenberg, J. U. Stolzenburg, M. C. Truss
Festsaal
Chair:
Edoardo S. Pescatori, Italy
Panel:
Juza Chen, Israel
Konstantinos Hatzimouratidis, Greece
Trygve Talseth, Norway
Walter Stackl, Austria
P-6
P-06-053
Zeremoniensaal
Erectile
Dysfunction
following
Prostatectomy
Chairs:
Bob Djavan, Austria
Radical
P-06-049
Identification of predictors of
functional outcome of open nervesparing radical prostatectomy
S. Joniau, Belgium
H. van Poppel, H. Claes, M. Albersen
P-06-050
Severe drop-off rate from the treatment for erectile dysfunction in noncounselled patients after bilateral
nerve sparing radical prostatectomy
(bnsrrp)
A. Gallina, G. Zanni, A. Briganti,
F. Deho, N. Suardi, A. Sacca, U. Capitanio,
G. Petralia, P. Rigatti, F. Montorsi
P-06-051
The impact of nerve sparing surgery
and the recovery of erections on
penile shortening after radical prostatectomy
Mario Galzerano, Italy
C. Magnani, L. Castigli, N. Mondaini,
P. Gontero
P-06-052
Histological alterations in cavernous
tissue after radical prostatectomy
Paolo Verze, Italy
F. Iacono, C. Imbimbo, F. Fusco,
N. Longo, F. Mangiapia, V. Mirone
SCIENTIFIC PROGRAM
C-7
08.00 - 09.30
B-4
Forum
Basics in Female Sexual Health
Chair:
C-07-01
Definitions, prevalence and riskfactors
Kerstin Fugl-Meyer, Sweden
C-07-02
Diabetes and FSD
Paul Enzlin, Belgium
C-07-03
Non-pharmacological treatment
Agnes Kocsis, United Kingdom
C-07-04
Pharmacological treatment
ML-8
P-07-059
Total phalloplasty using musculocutaneous latissimus dorsi free transfer flap - penile size according to the
patients wish
M. Djordjevic, M. Bumbasirevic,
R. Djinovic, S. Sansalone
P-07-060
Efficacy of Injectable mixed collagenase subtypes for Peyronie’s disease:
Treatment-related improvements in
sexual function and sexual satisfaction
Gerald Jordan, USA
P-07-061
Tight-skin (Tsk) mice as new experimental model of Peyronie’s disease
Raffaella Sorrentino, Italy
F. Fusco, A. Palmieri, R. D’Emmanuele di
Villabianca, D. Arcaniolo, P. Verze,
V. Mirone
P-07-062
Penile prosthesis in patients with
Peyronie’s disease: Our tips and
tricks
Peter Scheplev, Russia
I. Danilov, B. Gvasaliya, N. Garin
P-07-063
Total phallic construction using the
forearm free flap
N. Christopher, D. Ralph
The ESDA Experience
Chair:
Antoine Lemaire, France
R-03-01
The role of the European Alliance
Milly Lemos, Spain
R-03-02
The relation between ESDA and
scientific societies
Stamatis Papacharitou, Greece
R-03-03
Why patients with sexual difficulties do not take medical advice?
Antoine Lemaire, France
Zeremoniensaal
Surgery and Peyronie’s Disease
Chairs:
Stephane Droupy, France
Edoardo Austoni, Italy
Festsaal
Zeremoniensaal
Podium Session
10.30 - 12.00
Round Table
10.00 - 10.30
Festsaal
Ejaculatory and Orgasmic Disorders
Chairs:
Kerstin Fugl-Meyer, Sweden
Master Lecture
Drug Misuse and Sexual Function the Case of Heroin Addiction
Chair:
Speaker:
Antonio Palha, Portugal
R-3
10.30 - 12.00
P-7
10.00 - 10.30
Best Papers
39
40
SCIENTIFIC PROGRAM
P-07-064
Implantation of inflatable penile
prosthesis without dilatation of the
corpora. Analysis of 50 consecutive
cases
J. Jara, J. I. Martinez-Salamanca,
R. Cabello, J. I. Monzo, C. Hernandez
P-07-065
Concurrent dual inflatable penile
prosthesis and incontinence implant
(AMS-1500) after radical surgery.
Transversal incision approach. Our
preliminary experience
Omid Sedigh, Italy
M. Paradiso, M. E. Graziano, R. Rossi,
U. Ferrando
P-07-066
The role of preoperative MRI in revision penile implant surgery
C. Li, United Kingdom
P. Anderson, D. Ralph, S. Minhas
P-07-067
Infection rate after implantation of
three-component penile prosthesis
using a new pre- and postoperative
protocol: Short term follow-up
Federico Deho, Italy
G. Henry, A. Salonia, A. Briganti,
G. Zanni, G. Savoca, F. Abdollah,
R. Matloob, P. Rigatti, F. Montorsi
P-07-068
MP-5
Frenular grafting - An alternative to
circumcision
O. Keyes, S. Minhas, N. Christopher,
D. Ralph
10.30 - 12.00
Forum
General Issues in Sexual Medicine
Chairs:
Nuno Monteiro Pereira, Portugal
MP-05-129 Plasma levels of dihydrotestosterone remain in the normal range in
men treated with long-acting parenteral testosterone undecanoate
Aksam Yassin, Germany
F. Saad
MP-05-130 Elevation of Asymmetrical Dimethylarginine (ADMA) in men with
erectile dysfunction and metabolic
syndrome
Safar Gamidov, Russia
E. Mazo, V. Iremashvili
MP-05-131 Erection hardness is critical for good
sex and a healthy relationship: The
global better sex survey
K.-P. Juenemann, J. P. Mulhall,
V. Stecher
MP-05-132 Evolution with age of thoughts and
views on sexual function & relationship in the 50+ population in
Belgium
Hubert Claes, Belgium
H. van Poppel
MP-05-133 Is there a link between erection
hardness and overall health? Results
of the global better sex survey
Rosie King, Australia
V. Lehmann, I. Levinson
MP-05-134 Clinical characteristics of erectile
dysfunction patients with and
without metabolic syndrome
Evsey Mazo, Russia
S. Gamidov, V. Iremashvili
MP-05-135 Erectile dysfunction and men’s
health: Developing a comorbidity
risk calculator
M. Sand
MP-05-136 Socio-economic factors and sexual
dysfunction in both genders results
of the crossover-study „The Cologne
20.000 community survey“
Joanna Beate Korda, Germany
K. Motia-Sharei, M. Braun, H. Christ,
M. Hellmich, U. Engelmann
MP-05-137 NPT-test: How to reduce the false
positives?
A. L. Romano, C. Guerrer, A. Guarneri,
E. Austoni
SCIENTIFIC PROGRAM
MP-05-138 Does postejaculatory early voiding
cause to nonbacterial prostatitis?
Ali Atan, Turkey
M. M. Basar, A. Tuncel, Y. Aslan
MP-05-139 The importance of and satisfaction
with sex in Europe: Regional analysis of the global better sex survey
K.-P. Juenemann, M. Kirby, I. Levinson
MP-05-140 Severe obstructive sleep apnea syndrome is associated with female
sexual dysfunction
Mustafa Delibas, Turkey
Z. Z. Ucar
MP-05-141 Public-awareness does not promote
a shortening of the delay in first
seeking medical help for erectile
dysfunction (ed) in the pde5-is era.
Preliminary results at single major
tertiary academic centre
F. Pellucchi, R. Castillejos Molina,
A. Briganti, F. Deho, A. Gallina, G. Zanni,
N. Suardi, P. Rigatti, F. Montorsi
10th Congress of the
European Society
for Sexual Medicine
25 - 28 November 2007
Lisbon • Portugal
www.essm.org
MP-05-142 Time effect on potency in post-radical cystectomy patients: Subjective
and objective evaluation
Ehab Hekal, Egypt
A. Mesbah, M. El-Bahnasawy, A. El-Assmy,
M. Abdel-Latif, A. Shaaban
MP-05-143 How to improve the quality of life
at male population over 50 years
old with erectile dysfunction
Daniel Porav-Hodade, Romania
N. Crisan, B. Feciche, Z. A. Mihaly,
I. Coman
See you in
LISBON 2007
Closing Remarks
12.00 - 12.30
Festsaal
41
42
POSTER PRESENTATIONS
Monday, 4 December Wednesday, 6 December 2006
The poster exhibition will be located at the
Gardehalle I and II next to the main meeting halls
and the registration counter on the ground floor of
the Vienna Hofburg. The poster exhibition is open
to all conference delegates on:
The moderated posters will be located in front of
the Forum at the Gardehalle I and II or in the
Forum where the moderated poster session will
take place. The posters will be changed daily in the
room according to the sessions.
09.00 h - 17.30 h
09.00 h - 17.30 h
Wednesday, 6 December 2006 09.00 h - 12.30 h
Interested participants can meet the authors for
discussions of their poster presentation during the
following time:
The unmoderated posters will be arranged
according to topics and will be numbered within
these topics and will be set up for the whole period
of the congress in the Gardehalle I and II. The
Gardehalle I and II are directly situated in front of
the Forum.
PP-01
15.00 h - 15.30 h
15.00 h - 15.30 h
Poster Presentation
Pharmacology
PP-01-144
Does treatment with sildenafil
improve quality of sexual life in a
group of patients without sexual
dysfunction? Interim analysis
O. Massarwa
PP-01-145
Treatment of post radical prostatectomy (PRP) sexual dysfunction with
combined therapy of sildenafil and
intracavernosal alprostadil (pge1)
John Vlachiotis, Greece
D. Petsis, G. Perlepes, N. Zozas, A. Tsidavis
PP-01-146
Alfuzosin pharmacotherapy for
primary premature ejaculation
Vipan Bhatia, United Arab Emirates
PP-01-147
Factors Influencing Preference for
Tadalafil and Sildenafil Citrate (Sildenafil) in a Crossover Study Treating
Erectile Dysfunction in Men Naïve to
Phosphodiesterase 5 Inhibitor Therapy
F. Montorsi, M. Chan, K. Loughney,
G. M. Vail, A. Beardsworth
PP-01-148
Tadalafil improves psychological
aspects of sexual life in patients formerly treated by short-acting ED
medication
Juha Koskimaki, Finland
M. Leinonen, A. Cameron, P. Saloranta,
E. S. Leinonen
PP-01-149
PP-01-150
PP-01-151
PP-01-152
PP-01-153
PP-01-154
The Efficacy and Safety of tadalafil
10mg and 20mg in Japanese men
with erectile dysfunction (ed) and a
comparison of tadalafil doses in
Japanese men with severe ed
Yasusuke Kimoto, Japan
K. Nagao, K. Marumo, A. Tsujimura,
N. Ishii, K. Fujimoto, T. Imaoka,
D. Stothard, S. Watts, J. McGill,
S. Kamidono
Treatment patterns over 6 months
with PDE5 inhibitors in the erectile
dysfunction observational study
(EDOS)
Anthony Beardsworth, USA
A. Martin-Morales, A. von Keitz,
D. Hatzichristou, A. Riley
Satisfaction with erection hardness
and overall sexual experience in
men with Erectile Dysfunction (ED)
treated with tadalafil
I. Moncada, D. J. Ralph, V. Mirone,
M. Sotomayor, D. Stothard, S. Watts,
A. Beardsworth
Evaluation of the treatment results
and adaptation to treatment in the
PDE5 inhibitor therapy among erectile dysfunction patients
Sertac Cimen, Turkey
O. Demir, G. Aslan, A. Esen
Erectile dysfunction and anxiety:
The role of escitalopram. A preliminary study
Giorgio Corretti, Italy
I. Baldi
Long-term
administration
of
Udenafil, PDE type 5 inhibitor, helps
to preserve erectile function in rats
exposed to alcohol
Gook Jun Ahn, Republic of Korea
J. H. Sin, K. K. Kang, B. O. Ahn, M. Yoo
PP-01-155
Effectiveness and satisfaction with
tadalafil in patients changing PDE5
inhibitor treatment: Results from
the DETECT study
Thierry Roumeguere, Belgium
S. Arver, T. Eliasson, M. Belger,
H. Schmitt
PP-01-156
The Real - Life Safety and Efficacy of
Vardenafil (REALISE) Study - Results
from Belgium
Thierry Roumeguere, Belgium
H. Claes, H. van Poppel, C. Schulman,
H. Handel
PP-01-157
The influence of vardenafil on quality sexual life in aging men with
erectile dysfunction and diabetes
mellitus
Jacek Huk, Poland
M. Fryczkowski, Z. Kaletka, M. Szwedowski
PP-01-158
Attitudes of patients & physicians to
the use of vardenafil in the Belgian
population
T. Roumeguere, H. van Poppel, C. Schulman, H. Landen
PP-01-159
A sample analysis of patients in
whom Phosphodiesterase Type-5 inhibitors treatment failed or was
contraindicated
Shawket Alkhayal, United Kingdom
D. Backett, V. Lehmann
PP-01-160
Efficacy and safety of sildenafil
citrate in management of erectile
dysfunction following radical retropubic prostatectomy
Milos Brodak, Czech Republic
P. Navratil, J. Pacovsky
PP-01-161
Plasma levels of von Willebrand factor are lowered after treatment
with 25 mg of sildenafil daily
Angelis Konstantinopoulos, Greece
S. Raptis, K. Gyftopoulos, K. Giannitsas,
D. Spathas, P. Perimenis
43
44
PP-01-162
Sildenafil reduces pudendal artery
vascular resistance in the anaesthetised dog
Chris Wayman, United Kingdom
S. Hornby, A. Burden, N. Edmunds,
J. Casey
PP-01-169
Improvement of erectile function
and fertility with Prelox. A placebocontrolled, double-blind, cross-over
study
Romil Stanislavov, Bulgaria
V. Nikolova, P. Rohdewald
PP-01-163
Pharmacokinetic-pharmacodynamic
(PKPD) data demonstrates different
erectogenic response-plasma exposure relationships for sildenafil,
tadalafil, vardenafil, UK-343,664 &
UK-357,903
Chris Wayman, United Kingdom
S. Hornby, M. Price, L. Foster, A. Carter
PP-01-170
Efficacy of sildenafil still maintained
after 3 years of treatment despite a
2-month treatment pause
A. Morales, I. Defoy
PP-01-171
Sildenafil improves depressive symptoms of men with ED and untreated
depression not otherwise specified
Helene Dugre, Canada
S. Kennedy, P. D’Angelo, M. Sunderland, I. Defoy
PP-01-172
Treatment satisfaction with sildenafil in a Canadian real-life setting
G. Brock, R. Casey, J.-E. Tarride,
P. D’Angelo, S. Elliott, H. Dugre,
C. Rousseau, I. Defoy
PP-01-173
Men with erectile dysfunction may
achieve a second erection with vardenafil, in a home setting
Ray Rosen, USA
J. McMurray, K. Bangerter, A. Mazzu
PP-01-174
The in-vivo and in-vitro effects of
vardenafil on corpus cavernosal
smooth muscle relaxation in diabetic
rabbits
David Lau, United Kingdom
C. Thompson, D. Mikhailidis, F. Mumtaz
PP-01-175
Effectiveness and patient satisfaction
with 6 months tadalafil treatment:
Results from the DETECT study
Benny Verheyden, Belgium
T. Roumeguere, A. Bitton, E. Roos,
M. Belger, H. Schmitt
PP-01-164
Results of the use of vardenafil in
“non-demand” regimen
Andrey Vinarov, Russia
N. Akhvlediani
PP-01-165
The Real-Life Safety and Efficacy of
Vardenafil (REALISE)? An international post-marketing surveillance
study: Pooled results from 11 European countries
Jürgen Zumbe, Germany
H. van Ahlen, Z. Kopa, F. Trinkler,
H. Landen
PP-01-166
PP-01-167
PP-01-168
A comparison of vardenafil and sildenafil: Diary-recorded outcomes in
men with erectile dysfunction and
cardiovascular risk factors
H. Porst, I. Eardley, I. Goldstein
In a clinical setting using VSS, men
with ED may achieve a second erection with vardenafil
Ray Rosen, USA
J. McMurray, K. Bangerter, A. Mazzu
Erection hardness correlates positively with score on the quality of
erection questionnaire (qeq): A double-blind, placebo-controlled multinational trial of flexible-dose
Viagra® (Sildenafil Citrate)
Andrzej Depko, Poland
A. Kadlioglu, W. Grohmann, I. Levinson,
F. Sun, S. Collins
PP-02
Poster Presentation
PP-02-183
Preliminary results of post radical
prostatectomy (prp) penile length
John Vlachiotis, Greece
D. Petsis, G. Perlepes, K. Spiliopoulos,
A. Tsidavis
PP-02-184
Sexual function in rats with testicular dysgenesis
Konstantinos Karakitsios, Greece
H. Kawamura, N. Pardalidis, E. Grameniatis, D. Baltogiannis, N. Sofikitis
PP-02-185
The padam and expression of genes
of several proliferation factors
Alexander Pechersky, Russia
O. Loran, V. Pechersky, M. Vonsky,
A. Mittenberg, V. Semiglazov
PP-02-186
The padam and regulation of the
pulse mode of incretion of some
hormones
Alexander Pechersky, Russia
V. Semiglazov, O. Loran, A. Karpischenko, V. Pechersky, V. Mazurov
Risk factors, Hormones and Epidemiology
PP-02-176
PP-02-177
Effects of hyperbaric oxygen therapy
(HOT) on total testosterone (TT)
blood serum concentration
Giandomenico Passavanti, Italy
V. Pizzuti, M. Carlucci, M. Brauzzi,
P. Tanasi, R. Pagni, E. Norgini, R. Paolini,
A. Aloisi
Erectile dysfunction severity might
be associated with poor cardiovascular prognosis in diabetic men
Dan Justo, Israel
I. Uri, Y. Arbel, M. Swartzon, S. Galor,
R. Heruti
PP-02-178
The prevalence of erectile dysfunction
and its risk factors among nearly
10,000 men ages 25-55 years
Dan Justo, Israel
T. Shochat, S. Galor, R. Heruti
PP-02-179
The effect of coronary artery bypass
surgery on erectile function and
related quality of life
Matthew Hotston, United Kingdom
R. Jones, G. Angelini, J. Jeremy,
R. Persad
PP-02-187
Correlation of aortic stiffness with
severity of erectile dysfunction
Nikolaos Ioakimidis, Greece
C. Vlachopoulos, K. Rokkas, A. Tsokanis, N. Alexopoulos, C. Fassoulakis,
PP-02-180
Early rehabilitation & nerve sparing
cystectomy. Is there any value?
Ehab Hekal, Egypt
A. Mesbah, M. El-Bahnasawy, A. ElAssmy, M. Abdel-Latif, A. Shaaban
PP-02-188
PP-02-181
The realtionship between chronic
obstructive pulmonary disease and
erectile dysfunction: A comparative
study
Mustafa Faruk Usta, Turkey
O. Ozbudak, A. Cilli, E. Guntekin,
T. Koksal, T. Ozdemir
Contraction and relaxation response
of rabbit corpus cavernosum to partial bladder outlet obstruction: A
direct comparison of 2- and 4-week
Omer Demir, Turkey
E. C. Esen, N. Murat, G. Aslan,
S. Gidener
PP-02-189
Patient preferences in treatment of
erectile dysfunction after cryoablation of prostate for prostate cancer
Leonid Lobik, Israel
M. Hassan, D. Shumalinsky, D. Kesari,
A. Paz, S. Kravchick, S. Cytron
PP-02-182
ED: A cue for wider health risk
assessments?
Wendy Hurn, United Kingdom
D. Rutherford, R. Etherington, P. Aslet,
V. Griffiths
45
46
PP-02-190
Erectile dysfunction obesity and metabolic syndrome - A multicenter study
Aristomenis Gekas, Greece
C. Konstantinidis, P. Kartsaklis, I. Palaiodimos, S. Andreadakis, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis
PP-02-197
The role of sexual dysfunctions in
inducing the use of drug in males:
Preliminary results
Giuseppe La Pera, Italy
F. Peris, A. Carderi, Z. Marianantoni,
S. Livi, T. Macchia
PP-02-191
Premature ejaculation treated with
sildenafil. A multicenter study
Sotrios Andreadakis, Greece
C. Konstantinidis, P. Kartsaklis, I. Palaiodimos, A. Gekas, D. Delakas
PP-02-198
Sexual dysfunction in obese patients
Pinar Kadioglu, Turkey
D. Ozgil Yetkin, A. Serap Yalin,
K. Onem, A. Kadioglu
PP-02-199
PP-02-192
Microvascular complications and
diabetic neuropathy are more
important risk factors for diabetic
erectile dysfunction, than macrovascular disturbances.
Zdravko Kamenov, Bulgaria
V. Christov, T. Yankova
Outcomes of testosteron therapy in
impotent patients with metabolic
syndrom and hypogonadism
Murat Cakan, Turkey
F. Demirel, M. Topcuoglu, U. Altug
PP-02-200
Stable testosterone levels achieved
with subcutaneous testosterone
injections
Michael Greenspan, Canada
PP-02-201
Sexual problems in Romanian active
male population
Nicolae Calomfirescu, Romania
S. Fiica, C. Belinski, D. Gaita,
D. L. Bucuras, A. Cambosie, M. Mota,
A. Bulai, A. Study Group
PP-02-202
Testosterone gel associated to tadalafil in the therapy of diabetic
patients affected by erectile deficit
Enrico Spera, Italy
M. Scarfini, E. Vannozzi, A. De Carolis
PP-02-203
The recovery of sexual function in
patients with prostate cancer, obtaining antiandrogen therapy: Use of
vacuum devices and PDE5 inhibitors
Maksim Romanyuk, Ukraine
I. Gorpinchenko, S. Shamraev
PP-02-204
Early therapy following nerve sparing radicalprostatectomy (rp):
Improvement with combination
alprostadil + oral sildenafil
Marco Bitelli, Italy
A. Zucchi, G. Virgili, E. Spera, M. Pietrantuono, M. Valitutti, G. Vespasiani
PP-02-193
PP-02-194
PP-02-195
PP-02-196
Combined reporting of functional
and oncological results following
open radical prostatectomy using
the ‘Salomon-score’.
Steven Joniau, Belgium
M. Albersen, H. van Poppel, H. Claes
Testosterone and erectile function in
hypogonadal men unresponsive to
PDE5 Inhibitors: Results from an
open-label uncontrolled study
H. van Poppel
A comparison of ncep-atp-iii and idf
metabolic syndrome definitions
with relation to metabolic syndrome associated sexual dysfunction
E. Mannucci, L. Petrone, F. Lotti,
A. D. Fisher, C. Schulman, G. Balercia,
G. Forti, M. Maggi
An androgen-dependent PDE5 activity
in bladder might contribute to LUTS
Sandra Filippi, Italy
A. Morelli, P. Sandner, B. Fibbi,
R. Mancina, M. Marini, M. Gacci,
L. Vignozzi, G. B. Vannelli, M. Carini,
G. Forti, M. Maggi
PP-02-205
Sexual factors and prostate cancer
Elena Longhi, Italy
A. Salonia, R. Colombo, A. Briganti,
P. Rigatti, F. Montorsi
PP-02-206
In vitro effects of androgens on
cyclic AMP and cyclic GMP levels in
isolated human cavernous arteries
(HCA) and corpus cavernosum (HCC)
S. Ueckert, C. Bruns, D. Schultheiss,
M. Sohn, U. Jonas, K.-E. Andersson,
C. G. Stief, P. Hedlund
PP-02-207
PP-02-208
The erectile dysfunction in the alcohol drinking with low, medium and
high risc
Giuseppe Dachille, Italy
V. Giovanni, G. Cardo, F. Maselli,
M. Erinnio, G. M. Ludovico
Is ED in patients with LUTS managed adequately in primary care? An
audit of the current practice
Sudhanshu Chitale, United Kingdom
R. Collins, S. Hull, S. Irving
PP-02-209
Frequency rate of erectile dysfunction
in patients with arterial hypertension
Iakov Kan, Russia
PP-02-210
Sex hormones regulation in males
with maldescendent testes
Vitaliy Luchitskiy, Ukraine
PP-02-211
PP-02-212
Erectile Dysfunction and South
Asians: What determines whether
participants seek healthcare? An
ethnography centred in Oxfordshire
and Sri Lanka
David Edwards, United Kingdom
Male Chlamydia self-testing
Ian Banks, United Kingdom
D. Wilkins
PP-02-213
Ultrastructural characterization and
immunohistochemical study of
expression of Ang1, Ang2 and Tie-2
in corpus cavernosum of erectile
dysfunction-prone rat models
Pedro Vendeira, Portugal
J. Santos, A. Cordeiro, A. Figueiredo,
F. Godinho, I. Martins, H. Almeida,
D. Neves
PP-02-214
Testosterone is the therapeutical
Bridge between Metabolic Syndrome and Erectile Dysfunction
Farid Saad, Germany
A. Yassin, R. Shabsigh, A. Traish,
S. Kalinchenko, I. Eardley
PP-02-215
Two modern modes of testosterone
treatment compared: Transdermal
testosterone gel and injectable
long-acting testosterone undecanoate
Aksam Yassin, Germany
A. Haider, F. Saad
PP-02-216
Does intracavernous rehabilitation
of erectile function after nerve-sparing radical prostatectomy improve
post-operative urinary stress-incontinence?
Massimo Polito, Italy
W. Giannubilo, M. Leone, G. d’Anzeo,
G. Muzzonigro
PP-02-217
Correlation between hemodinamic
and clinical results of penile color
Doppler ultrasound and risk factors
for erectile dysfunction
F. Boezio, V. Stellacci, G. Lucarelli,
P. Ditonno, M. Battaglia, F. P. Selvaggi
PP-02-218
Testosterone gel therapy for LUTS in
male patients: A treatment option
A. Guarneri, A. L. Romano, E. Inneo,
E. Austoni
47
48
PP-02-219
The quality of life, sexuality and
cognitive functions in patients diagnosed with PADAM
Krzysztof Nowosielski, Poland
V. Skrzypulec, A. Sipinski, A. Drosdzol
PP-02-220
Histopathological proved prevention
of post-prostatectomy cavernosal
fibrosis with a PDE5 inhibitor
Fabrizio Iacona, Italy
D. Prezioso, P. Somma, S. Chierchia,
R. Galasso, M. Di Martino
PP-03
Poster Presentation
Female sexual function and dysfunction
PP-03-221
Correlation between FSFI scores and
sexual dysfunction in male partners
in a random sample of registered
nurses: The Nurses Sexuality Study
PP-03-222
Comparison of normative and
menopausal women by the Brief
Index of Sexual Functioning for
Women (BISF-W)
Heung-Yeol Kim, Republic of Korea
C.-Y. Huh, D.-H. Bae, J.-S. Kang,
D.-H. Kim, S.-Y. Hong, S.-T. Oh,
K.-H. Lee, S.-H. Cho, S.-R. Kim, M.-H. Jung
PP-03-223
Association of Women’s FSFI Scores
and sexual dysfunction in male partners in a sample of registered
nurses: The Nurses Sexuality Study
PP-03-224
Sexual dysfunction in women with
end stage renal disease and the
investigation of risk factors
Elife Kettas, Turkey
F. Cayan, E. Akbay, A. Kiykim, S. Cayan
PP-03-225
Prevalence of sexual disorders in
women patients consulted urology
clinics
Adil Esen, Turkey
H. Sicramaz, A. Sahin, O. Demir,
D. Turan, E. Can
PP-03-226
Risk factors of female sexual disorders
Adil Esen, Turkey
A. Sahin, H. Sicramaz, O. Demir, E. Bal,
E. Can
PP-03-227
The combined use of brachial artery
flow mediated dilatation and carotid artery intima media thickness
measurements is an alternative
method to penile color doppler
ultrasonography
Gokhan Ucar, Turkey
M. Secil, O. Demir, T. Demir,
A. Comlekci, S. Caliskan, A. Esen
PP-03-228
Penile Doppler findings of arterial
flow in relation to vascular risk factors in patients with erectile dysfunction
C. Vlachopoulos, N. Ioakimidis,
G. Antoniou, A. Tsokanis, A. Bratsas,
PP-03-229
Aortic stiffness and carotid intima
media thickness are associated with
penile Doppler findings in patients
with vasculogenic erectile dysfunction
N. Ioakeimidis, D. Tsekoura, K. Rokkas,
K. Aznaouridis, P. Pietri, A. Askitis,
C. Stefanadis
PP-03-230
Plasma concentration of asymmetric
dimethylarginine (ADMA) in relation
to vasculogenic erectile dysfunction
in patients with and without coronary artery disease
Nikolaos Ioakeimidis, Greece
C. Vlachopoulos, C. Vasiliadou,
K. Rokkas, A. Bratsas, G. Siasos,
PP-03-231
Temporal relationship between
erectile dysfunction, cardiovascular
disease and quality of life
Lynette Hodges, United Kingdom
M. Kirby, J. O’Donnell, D. Brodie
PP-03-232
Arterial stiffness predicts the level
of the pharmacological induced
erectile response in metabolic syndrome
Vasile Coca, Romania
PP-03-233
Sexual problems in hypertensive
Turkish women in Turkey and
Germany: A transcultural study
Esma Demirezen, Turkey
U. Henke, O. Sanli, A. Kadioglu
PP-03-235
Prevalence of sexual dysfunction in
women over 20 years of age in
Istanbul
Ergul Aslan, Turkey
N. Kizilkaya Beji, I. Gungor, A. Kadioglu,
B. Kucuk Dikencik
PP-03-236
Relaxation of isolated rat vaginal
strips and clitoral corpus cavernosum by PDE5 inhibitors
Hanna Tinel, Germany
J. Huetter, P. Sandner
PP-03-237
Mild genital prolapse does not
affect female sexual function
Hyun Hee Cho, Republic of Korea
J. Kim, J. Kim, M. Kim, Y. Rhew,
D. Kwon, L. YoungTaek, H. Youn,
M. Jung, C. Jun
PP-03-238
The Effects of vaginal birth on postpartum sexual function
Gulay Yildirim, Turkey
N. Kizilkaya Beji, N. Comert, B. Kucuk
Dikencik, A. I. Tekirdag, A. Kadioglu
PP-03-239
Evaluation of female sexual function
in patients underwent surgery for
urogenital prolapse
Alessandro Zucchi, Italy
E. Costantini, A. Giannantoni, F. Fioretti,
M. Bitelli, L. Mearini
PP-03-240
Sexual health of women married to
men suffering from the vascular
form of sexual dysfunctions
Igor Gorpinchenko, Ukraine
O. Romashchenko, S. Melnikov,
V. Bilogolovskaya
PP-03-241
Sexual dysfunction among female
patients with Behcet’s disease
Pinar Kadioglu, Turkey
D. Ozgil Yetkin, S. Aliustaoglu, A. S. Yalin,
G. Hatemi, G. Oral, A. Kadioglu
PP-03-242
The effect of pregnancy and postpartum period on female sexual
function
M. Resit Goren, Turkey
L. Peskircioglu, N. Acar, H. Ozkardes
PP-03-243
Is there an association between
menopause, mood status and sexual
functioning?
Gabriella Gyovai, Hungary
C. Huszka, A. Lakatos, F. Racz, T. Nyari,
G. Ugocsai
PP-03-244
Urinary incontinence in women:
A questionnaire study of social and
sexual quality of life
Andrea Ceresoli, Italy
F. Colombo, A. L. Romano, L. Rivolta,
E. Austoni
PP-04
Poster Presentation
Ejaculatory disorders
PP-04-245
Sacrolumbar intersegmental reflex
circuit in men
Baris Altay, Turkey
C. Ertekin, F. Bademkiran, H. Uysal
PP-04-246
Experience with evaluation of premature ejaculation /pe/
Ferenc Fekete, Hungary
A. Rusz, I. Romics
49
50
PP-04-247
Ejaculation latency times and their
relationship with penile sensitivity
in men with normal sexual function
Hilde Vanden Broucke, Belgium
K. Everaert, W. Peersman, H. Claes,
D. Vanderschueren, M. van Kampen
PP-05-254
Male to female Sex Reassignment
Surgery (SRS): Comparison of two
techniques
Paolo Verze, Italy
C. Imbimbo, A. Palmieri, N. Longo,
C. Barba, D. Arcaniolo, V. Mirone
PP-04-248
Relaxory neurotransmitter modulating the contractility of smooth
muscle from seminalvesicle
Weifu Wang, People’s Republic of China
C. Wu, C. Fry, S. Minhas, D. Ralph
PP-05-255
Augmentation Phalloplasty: Apical
and pericavernousal penile implant
Jamal Salhi, Italy
M. del Prete
PP-05-256
PP-04-249
Relaxory neurotransmitter modulating the contractility of smooth
muscle from vas deferens
Weifu Wang, People’s Republic of China
C. Fry, C. Wu, S. Minhas, D. Ralph
Permanent penile lengthening byintracavernous injection of n-butyl-2cyanoacrylate in dogs
Fathy Moossa, Egypt
K. Farag
PP-05-257
Treatment of penile cripple after
operations for hypospadias
Wojciech Perdzynski, Poland
M. Adamek
PP-05-258
An audit of the presentation & management of ischaemic priapism
A. Adeniyi, United Kingdom
P. Anderson, P. Kumar, N. Christopher,
D. Ralph, S. Minhas
PP-05-259
Outcome from advanced penile
cancer? A UK series
O. Kayes, United Kingdom
P. Anderson, P. Hegarty, D. Ralph,
S. Minhas
PP-05-260
Webbed and buried penis - Surgical
approach
Aristomenis Gekas, Greece
P. Kartsaklis, I. Palaiodimos, S. Andreadakis, C. Konstantinidis, P. Stamopoulos, D. Baltogiannis, N. Sofikitis
PP-05-261
A case of penile fracture with complete urethral disruption during
sexual intercourse
Klemen Jagodic, Slovenia
M. Erklavec, I. Bizjak, S. Poteko,
H. Korosec Jagodic
PP-04-250
Premature ejaculation and heroin
use: Is there a link?
F. Peris, A. Carderi, Z. Marianantoni,
M. S. Fattori, F. Taggi
PP-04-251
Why combination treatment for premature ejaculation?
Michael A. Perelman, USA
PP-04-252
Premature Ejaculation: Psycho-social
background of patients and treatment preferences
I. Hattat, E. Akkus, B. Alici, H. Özkara
PP-05
Poster Presentation
Surgery, Priapism and Peyronie’s Disease
PP-05-253
Our experience with Methylene
Blue (methylthionine chloride MB)
in the treating of priapism
Giandomenico Passavanti, Italy
V. Pizzuti, E. Spinosa, A. M. Aloisi,
M. Carlucci, R. Paolini, A. Bragaglia
PP-05-262
Induratio penis plastica: Corporoplastic with small gauge malleable
semirigid penile implant and graft
of saphenous vein
Mauro Silvani, Italy
S. Quaranta, D. Concone, D. Minocci
PP-05-263
Extracorporeal Shock Wave Therapy
improves sexual performance and
satisfaction in patients with
Peyronie’s disease
Shawket Alkhayal, United Kingdom
G. John, M. Fletcher, V. Lehmann
PP-05-264
Paradoxical arterial priapism: Posttraumatic monolateral low penile
perfusion and curvature associated
to contro-lateral arterious-cavernous laceration and fistulization.
Ignazio Gattuccio, Italy
E. Italiano, F. Zangara, F. Montalto,
G. Savoca, S. Lo Giudice, M. Parrinello,
C. Gagliardo, F. Gattuccio
PP-05-265
Sex reassignment surgery for male
to female transsexuals: Initial experience
Rui Barbosa, Portugal
N. Tomada, P. Vendeira, A. Cardoso,
J. Reis, J. Amarante
PP-05-266
Development of approaches to estimate the implanted three-dimensional polymeric materials for tissue
engineering in genital surgery
N. Garin, B. Gvasaliya, S. Gusev,
G. Borisenko
PP-05-267
Risk factors in development of
recurrent urethral strictures after
urethroplasty
B. Gvasaliya, N. Garin
PP-05-268
Peyronie’s disease, total penile skin
necrosis and reconstruction with
scrotal flap in two steps: Case report
F. Peris, U. Anceschi, G. Maggiulli,
A. Felici, M. Lentini
PP-05-269
The treatment and outcomes in urethral squamous cell carcinoma
Frank Soden, United Kingdom
O. Kayes, A. Freeman, D. Ralph,
S. Minhas
PP-05-270
Fibroepithelial polyp of glans penis:
A case report
Roberto Sanseverino, Italy
A. Baio, O. Intilla, U. Di Mauro,
T. Realfonso, G. Napodano
PP-05-271
Clinical characterestics of patients
with Peyronie’s disease in a sexual
problems andrology outpatient clinic
Natarajan Kathirvel, United Kingdom
K. Wylie
PP-05-272
Shock-wave therapy for Peyronie’s
disease: High-energy shock waves
do not restore mechanism of corporal
venous occlusion
PP-05-273
Concomitant placement of male
sling with inflatable penile prosthesis
by unique penoscrotal incision
Luigi Rolle, Italy
I. Morra, C. Ceruti, F. Ragni,
A. Tamagnone, M. Timpano, C. Negro,
D. Fontana
PP-05-274
Penis (glans) carcinoma: Disassembly, glandsectomy and urethroglansplastic
Omid Sedigh, Italy
M. Paradiso, F. Varvello, F. Liberale,
M. E. Graziano, U. Ferrando
PP-05-275
Frenular Grafting ? An alternative to
circumcision
Amanda Spillings, United Kingdom
O. Kayes, L. Chi-Yi, C. Nim, S. Minhas,
D. Ralph
PP-05-276
The comparison of symptoms according to the phase of Peyronie’s
disease
Tolga Akman, Turkey
T. Oktar, O. Sanli, S. Guven,
M. F. Akbulut, A. Kadioglu
51
52
PP-05-277
Classification of disease of Peyronie
PP-05-278
Experience of surgical treatment of
patients with disease of Peyronie
E.
Stahovskiy,
Y.
Gurzhenko,
A. Kornienko
PP-05-279
PP-05-280
Stage of morphological evolution of
albumen shell of penis of patients
with disease Peyronie
State of hypophysial gonadal
system of patients with disease of
Peyronie
L. Imshinetskaya
PP-05-281
Ultrastructural characteristic of cellular elements of albumen shell of
penis at disease of Peyronie
PP-05-282
The corporoplasty with simultaneous penile prosthesis implantation
in Peyronie disease
Mikhail Sokolschik, Russia
R. Petrovich, S. Gagarina, Y. Vasiev,
I. Sadakova
PP-05-283
PP-05-284
PP-05-285
PP-05-286
Painful La Peyronie disease: Are
really inefficient the intracavernous
injections of corticoids?
Pierre Bondil, France
A. Demey, F. Ozone, B. Knouzy
PP-05-287
Rehabilitation after plastic penile
surgery
Wojciech Lauer, Poland
D. Perkowski, M. Markuszewski,
K. Krajka
PP-05-288
Surgical treatment of Peyronie
disease
Kazimierz Krajka, Poland
M. Matuszewski, W. Moszczynski
PP-05-289
Systemic vascular abnormalities in
Peyronie’s disease
Vineet Agrawal, United Kingdom
S. Minhas, E. Ellins, A. Donald, J. Halcox,
D. Ralph
PP-06
Poster Presentation
General Issues in Sexual Medicine
PP-06-290
Determination of Turkish patient
satisfaction after penile prosthesis
surgery
M. Resit Goren, Turkey
B. Cakar, L. Peskircioglu, H. Ozkardes
The real-life safety and efficacy of
vardenafil: An international postmarketing surveillance study results from 5373 Polish patients
Piotr Trypens, Poland
A. Depko, R. Dadej, H. Landen
PP-06-291
Idiopathic Priapism in patient with
Cerebellar Ataxia and left colon
neoplasm: A case report
Massimo Polito, Italy
W. Giannubilo, M. Leone, G. d’Anzeo,
M. Dellabella, G. Muzzonigro
Evaluation of a Sexual Assessment
Monitor (SAM); a diagnostic device
for premature ejaculation
W. Dinsmore, Ireland
D. Ralph, P. Kell, K. Wylie, J. Dean,
C. Novak, J. Wyllie, M. Wyllie
PP-06-292
Half of those reporting a sexual problem are satisfied with their sexual
function: Results from the Hoppes
study
M. Fridakis, E. Nakopoulou, R. Rosen,
Our experience of the evolution of
priapism
K. Bouraoui, F. Ozone, A. Demey,
F. Adawi
PP-06-293
Patients’ self-perception of sexual
function: Results from the HOPPES
study
M. Fridakis, G. Salpiggidis, R. Rosen,
PP-06-294
Perceptions about sexual health
issues in nursing
Evangelia Nakopoulou, Greece
S.
Papaharitou,
M.
Moraitou,
F. Ferenidou, L. Athanasiadis
PP-06-295
Presence of sexual problems may
not indicate dissatisfaction from
sexual life: Results from the HOPPES
study
M. Fridakis, S. Papacharitou, R. Rosen,
J. Mckinlay, D. Hatzichristou
PP-06-296
Treatment seeking behavior for
sexual problems: Results from the
HOPPES study
M. Fridakis, K. Hatzimouratidis,
R. Rosen, J. Mckinlay, D. Hatzichristou
PP-06-297
Prevalence and diversity of sexual
disorders among male and female
patients referred to family healthcare
clinic,Tehran- Iran
Mansour Ghavam, Iran
PP-06-298
Is there a significance of histamine
in the control of penile erection?
Armin J. Becker, Germany
S. Ückert, M. Schröder, F. Scheller,
U. Jonas, C. G. Stief
PP-06-300
A history of sexual abuse: How reliable is a self-administered questionnaire compared to an administered
questionnaire?
Henk Willem Elzevier, The Netherlands
P. J. Voorham van der Zalm, R. C. M. Pelger
PP-06-301
The use of sexual symbolism and
metaphor in the psychosexual treatment of male anorgasmia - a case
report
Susan Pacey, United Kingdom
PP-06-302
“san-sex.ro” - esda Romanian connection
A. Liiceanu, C. Belinski, D. Gaita,
S. Fiica, C. Calomfirescu, V. Arama,
A. Manu, V. Voinescu, V. Orsavski, SanSex Expert Group
PP-06-303
Sexual information level in active
women population in Romania
S. Fiica, C. Belinski, D. Gaita,
D. L. Bucuras, A. Cambosie, M. Mota,
A. Bulai, AMSR Study Group
PP-06-304
Remembered international index of
erectile function domain scores are
not accurate in assessing preoperative sexual function (sf) in candidates to bilateral nerve sparing radical
prostatectomy (bnsrp)
A. Gallina, G. Zanni, A. Briganti,
A. Sacca, F. Deho, U. Capitanio,
F. Pellucchi, F. Sozzi, P. Rigatti, F. Montorsi
PP-06-305
Potential impact of the educational
level impact on the rate of treatment
adherence in patients with erectile
dysfunction (ed). Results of a single
major tertiary acadamic centre
F. Abdullah, F. Pellucchi, R. Molina,
A. Briganti, G. Zanni, F. Deho,
G. Petralia, L. Barbieri, P. Rigatti, F. Montorsi
PP-06-306
Unsuccessful investigation of preoperative couple’s and sexual relationship issues in candidates to radical
prostatectomy
G. Zanni, U. Capitanio, A. Gallina,
A. Briganti, F. Deho, E. Strada, N. Suardi,
P. Rigatti, F. Montorsi
53
54
PP-06-308
A new model for a supraregional
penile cancer service utilising an
urgent fax response system and
regular teleconferenced multidisciplinary (MDT) meetings
Duncan Summerton, United Kingdom
N. Mayer, M. Bamford, A. Rajesh,
K. Mulcahy, T. Terry
PP-06-309
Pregnancy in adolescence
Isabel Guimaraes, Portugal
I. Almeida
PP-06-310
Autoerotic accidents in legal medicine
- a retrospective study of 17 cases
Knut Albrecht, Germany
F. Mansouri, D. Schultheiss, S. Ueckert,
U. Jonas, D. Breitmeier
PP-06-311
Our experience of male dyspareunia
F. Ozone, K. Bouraoui, A. Demey,
F. Adawi
PP-06-312
Analysis of data related to the
Siena’s experience during the
Prevention Week in Andrology, 2006
Roberto Ponchietti, Italy
V. Tallis, S. Trovarelli, E. Paliouri,
F. Trovarelli
PP-06-313
Characterization of the BDSM community in Portugal: An internet
based study
Patricia Pascoal, Portugal
R. Rui Henriques, N. Monteiro Pereira
PP-06-314
Body image and sexuality: Comparative study
Ana Filipa Beato, Portugal
P. Pascoal, I. Narciso Davide,
N. Monteiro Pereira
PP-06-315
Desire to improve sexual experiences and willingness to seek treatment for erectile dysfunction:
Results of the Global Better Sex
Survey
Michael Kirby, United Kingdom
S. Glina, Y. Vardi, K. Hvidsten
LIST OF EXHIBITORS
Exhibitors
Booth No.
Booth No. Exhibitors
Bayer HealthCare AG
Blackwell Publishing
EAU
ESDA
ESSM
10th ESSM Congress Lisbon
ISSM
Ipsen Pharma
Lilly ICOS LLC
Nature Publishing
Pfizer Inc.
Plethora Solutions/Timm
Medical Technologies
Schering AG
Uroan 21
6
1
8
14
3
15
16
18
19
17
11
7
2
10
1
2
3
4
5
Nature Publishing
Uroan 21
Plethora Solutions/Timm Medical
Technologies
Lilly ICOS LLC
Bayer HealthCare AG
Pfizer Inc.
Ipsen Pharma
Schering AG
Blackwell Publishing
EAU
ESDA
ISSM
ESSM
10th ESSM Congress Lisbon
6
7
8
9
10
11
12
13
14
15
16
17
18
19
5
9
13
12
4
Exhibition Plan - First Floor
18
1
2
17
3
19
8
7
6
15
16
4
5
9
10
Zeremoniensaal
11
12
Festsaal
13
14
55
56
LIST OF CHAIRPERSONS AND PRESENTERS
Name
Page
A
Name
Page
Bhatia, V.
30, 42
Abdo, C.
28
Bitelli, M.
46
Adeniyi, A.
50
Bitzer, J.
37
Agrawal, V.
36, 52
Boer, B.-J. de
36
Ahn, G. J.
Akkus, E.
43
Bondil, P.
52, 54
29, 37
Booth, C.
33
Akman, T.
51
Boul, L.
28
Albersen, M.
38
Briganti, A.
Albrecht, K.
54
Brock, G.
Alder, J.
32
Brodak, M.
Alkhayal, S.
Allers, K.
43, 51
Buvat, J.
33, 38
26, 34, 35
43
23, 25, 29
28
Altay, B.
26, 49
Anderson, P.
35, 36
Andreadakis, S.
46
Angulo Frutos, J.
28
Arver, S.
30, 36
Aslan, E.
49
Atan, A.
30, 41
Athanasiadis, L.
28
Aughton, K.
26
Austoni, E.
23, 39
Aversa, A.
29, 34
B
C
Cabral Ribeiro, J.
35
Cakan, M.
46
Calomfirescu, N.
46, 53
Carrier, S.
28, 44
Casey, R.
24
Cayan, S.
35
Ceresoli, A.
49
Chen, J.
Chevret Measson, M.
36, 37, 38
33
Chitale, S.
28, 47
Cho, H.H.
49
Cimen, S.
43
Banks, I.
47
Bannowsky, A.
38
Claes, H.
Barbosa, R.
51
Clement, P.
36
Coca, V.
49
30
40, 43, 46
Barnes, T.
30, 33
Basar, M.
29
Collins, S.
Beardsworth, A.
43
Colombo, F.
Becker, A. J.
53
Corona, G.
25, 28, 32, 46
Behre, H.
23
Corretti, G.
43
33, 34
Costa, P.
34
27, 30, 47
Cuzin, B.
29
Behr-Roussel, D.
Bettocchi, C.
23, 36, 38, 40, 47
Name
Page
D
Dachille, G.
47
Damsted Petersen, C.
31
Danes, B.
28
Name
Page
Fugl-Meyer, K.
39
Fusco, F.
36
G
Galzerano, M.
38
40
Gamidov, S.
40
Delibas, M.
41
Garaffa, G.
Demir, O.
45
Gattuccio, I.
Demirezen, E.
49
Gekas, A.
Dean, J.
23, 28, 37
Deho, F.
35, 39, 40
51
46, 50
Depko, A.
29, 44
Ghavam, M.
Dinsmore, W.
36, 52
Giraldi, A.
30, 31, 36
24, 39, 41
Djavan, B.
38
Giuliano, F.
Dogru, T.
32
Goldmeier, D.
Droupy, S.
39
Goldstein, I.
44
Golombok, S.
Dugre, H.
Gorpinchenko, I.
E
Greenspan, M.
Eardley, I.
23, 25, 36, 42
Gruenwald, I.
Ebert, A.
35
Guimaraes, I.
53
25
23, 26, 32, 40
26
49, 51, 52
46
39, 42
54
Edwards, D.
30, 47
Gurzhenko, Y.
Elzevier, H. W.
31, 53
Gutierrez, P. R.
33
Gyovai, G.
49
Enzlin, P.
39
Esen, A.
48
35, 52
H
F
Hackett, G.
28, 29, 34
Fekete, F.
49
Hallam, R.
28
Felblinger, D.
26
Haro, J.M.
34
Ferenidou, F.
27
Hattat, H.
50
Fernandez Lozano, A.
25
Hatzichristou, D.
25, 34
54
Hatzimouratidis, K.
29, 38
Filipa Beato, A.
Filippi, S.
25, 46
Hawcock, T.
27
Fisher, W.
29
Hedlund, H.
33
Franco, G.
36
Hedlund, P.
31
Fugl-Meyer, A.
27, 30
Hekal, E.
41, 45
57
58
Name
Hellstrom, W.
Page
31, 35, 43
Name
Page
Kimoto, Y.
43
40
Her, M.
26
King, R.
Heufelder, A.
23
Kirana, P.-S.
Hobbs, K.
32
Kirby, M.
Hodges, L.
48
Kocsis, A.
39
Hotston, M.
45
Konstantinopoulos, A.
43
Huk J.
43
Korda, J. B.
Huri, E.
49
Koskimaki, J.
42
Hurn, W.
45
Krajka, K.
52
Kristensen, E.
25
Kunelius, P.
38
I
Iacona, F.
Ioakimidis, N.
33, 52, 53
27, 54
26, 40
48
45, 48
J
L
La Pera, G.
46, 50, 51
Lackner, J.
33
Jackson, G.
23
Lau, D.
44
Jagodic, K.
50
Lauer, W.
52
39
Jannini, E.
28, 30
Lemaire, A.
Joniau, S.
38, 46
Lemos, M.
39
Jordan, G.
39
Letizia, P.
23
Juenemann, K.-P.
27
Li, C.
40
Jungwirth, A.
28
Lobik, L.
45
Justo, D.
45
Longhi, E.
Luchitskiy, V.
25, 47
47
K
Kadioglu, A.
23, 29, 34
M
Kadioglu, P.
46, 49
Maggi, M.
27
Kamenov, Z.
28, 46
Mancini, M.
30
Kan, I.
47
Martin-Morales, A.
Karakitsios, K.
45
Martinez-Salamanca, J. I.
24, 31
Kathirvel, N.
51
Mazo, E.
Kayes, O.
50
McMahon, C.
24
Kettas, E.
48
Meryn, S.
29
Kim, H.-Y.
48
Minhas, S.
35
28
33, 40
Name
Mirone, V.
Modi, N.
Moncada, I.
Monteiro Pereira, N.
Montorsi, F.
Page
31, 34
30
23, 28, 40
Name
Porav-Hodade, D.
Porst, H.
Pryor, J.
Page
41
35, 37
27
40
23, 25, 31
R
Moossa, F.
50
Ralph, D.
23, 27
Morelli, A.
34
Resit Goren, M.
49, 52
Mulhall, J.
27, 31
Murat, N.
32
N
Richards, N.
26
Richardson, D.
26
Riley, A.
34
Rokkas, K.
28, 32, 48
Nachtigall, L.
26
Rolle, L.
51
Nakopoulou, E.
53
Romanyuk, M.
46
Nicol, S.
28
Rosen, R.
35, 44
Nim, C.
35
Rossello Barbara,
M. 27
Nowosielski, K.
48
Roumeguere, T.
43
Rub, R.
36
P
Rubio-Aurioles, E.
Pacey, s.
53
Palha, P.
39
Papacharitou, S.
25, 39
Papadoukakis, S.
Paradiso, P.
27, 29, 30, 44
S
Saad, F.
47
38
Saenz de Tejada, I.
27
35
Salhi, J.
50
Pascoal, P.
26, 54
Salonia, A.
Passavanti, G.
45, 50
Sand, M.
31, 36, 38, 41, 53
26, 32, 48
Pechersky, A.
45
Sanseverino, R.
Perdzynski, W.
50
Scheplev, P.
39, 51
Schulman, C.
28, 31
Perelman, M. A.
Perovic, S.
31, 50
23, 35, 39
51
Schultheiss, D.
34
Schwenkhagen, A.
37
Pescatori, E. S.
38
Peskircioglu, L.
26, 27
Sedigh, O.
35, 40, 51
Plas, E.
23, 34
Shabsigh, R.
25, 36, 40
Polito, M.
47, 52
Silvani, M.
51
Simonelli, C.
33
Ponchietti, R.
54
59
60
Name
Page
Soden, F.
51
Sohn, M.
23, 37
Sokolschik, M.
35, 52
Sönksen, J.
34, 36
Sorrentino, R.
39
Spera, E.
46
Spillings, A.
27, 51
Stackl, W.
38
Stanislavov, R.
44
Stecher, V.
33
Stief, C.
27, 29, 35
Stien, R.
34
Studd, J.
32
Summerton, D.
54
Sungur, M.
33
Symonds, T.
37
T
Talseth, T.
38
Tinel, H.
49
Topic, B.
26
Trypens, P.
52
U
Ucar, G.
Ückert, S.
Usta, M. F.
48
33, 37, 39
29, 45
Name
Page
V
Vanden Broucke, H.
Vardi, Y.
Vendeira, P.
Verheyden, B.
Verze, P.
Vignozzi, L.
Vinarov, A.
Vlachiotis, J.
Vlachopoulos, C.
23, 25,
38,
25,
42,
28, 32, 33,
50
31
47
44
50
38
44
45
48
W
Waldinger, M. D.
Waldkirch, E.
Wang, W.
Wayman, C.
Wespes, E.
Wilson, L.
Wingen, G. van
Wylie, K.
Wyllie, M.
30 ,33
32, 47
50
44
34
32
32
28
37
Y
Yaman, O.
Yassin, A.
Yildirim, G.
33
40, 47
49
Z
Zucchi, A.
Zumbe, J.
49
44

TABLE OF CONTENTS

Transcription

Similar documents

Media : Metro Ahad Section : Setempat Date

L`ombelico del mondo

SEXtend \seks tend \ - Student Health Center

Intimissimi has a great history behind it. The extraordinary

The World Game. How t - The World Game Italy

www.fsnb.org.uk - Fresh Start New Beginnings

Erectile dysfunction and treatment options

Both WAVAW and SAS will support whatever decisions you make.